• Home
  • About Us
  • Health Insurance Companies

Health Plan News

Timely Health Plan News and Commmentary.

Health Plan News
Home Archives for Medical And Healthcare Facilities And Providers

Company Nurse Expands Its Injury Hotline for Workers’ Compensation

Posted on December 13, 2010 Written by Annalyn Frame

SOURCE: Company Nurse

The Expanded Nurse Call Center Will Address Growing Number of Public and Private Employers Who Want to Make the “Right Call” for Their Injured Workers

SCOTTSDALE, AZ–(Marketwire – December 13, 2010) – In striving to help a growing number of public and private employers control workers’ compensation costs and foster occupational health and safety, Company Nurse, the premier nurse hotline for workplace injuries, today announced that it has expanded its Scottsdale-based nurse triage call center.

When a workplace injury occurs, client employees and supervisors call Company Nurse to report injuries and to speak with a triage nurse. Unlike nurse case managers, triage nurses get involved at the front end of the claims process, essentially on the day of injury — which is the earliest, most critical point at which to influence medical care, claims costs, return-to-work (RTW) outcomes, and employee satisfaction. Many organizations view nurse injury triage as a vital part of their corporate wellness, employee wellness, and employee health programs.

“Our nurses assess injuries over the phone and refer employees to the most appropriate level of care — whether it’s an urgent care facility, occupational clinic, or simple first aid,” said Paul Binsfeld, CEO of Company Nurse. “As a result, our Injury Hotline facilitates immediate, critical medical decisions that positively impact an employee’s medical care, as well as overall claims’ costs and outcomes.”

The expanded Scottsdale-based call center works in sync with Company Nurse’s second call center in Tennessee. Due to growing nationwide demand for nurse injury triage for workers’ compensation, Company Nurse has grown 200 percent over the last four years and has recently moved into office space double its previous size to accommodate growing call center operations.

“During today’s difficult economy, employers need to minimize the financial impact of rising medical and indemnity costs on their workers’ compensation programs and bottom lines,” said Binsfeld. “Our program provides an effective solution to today’s most pressing workers’ compensation challenges: injuries are often reported late, sometimes five to 10 days after an incident has occurred; supervisors frequently err on the side of caution, sending employees, even those with minor injuries, to the ER for care; and many organizations are not optimally leveraging cost-effective preferred provider networks.”

Company Nurse’s Injury Hotline offers employers a proactive and structured response to each and every workplace injuries — 24 hours a day, 7 days a week. Triage nurses are highly compassionate and listen closely to each employee’s unique medical needs. Recognizing that organizations have specific workers’ compensation requirements, Company Nurse can customize its injury response and workflow to meet the client’s occupational health and safety needs.

Carol S. Sterling is the Human Resources Manager of the Boys & Girls Clubs of Metropolitan Phoenix. As an early adopter of the Company Nurse program, her organization experienced several key benefits. “First, we receive instant notification of injuries, so we can immediately file our first report of injury forms,” said Sterling. “Second, Company Nurse is extremely flexible. We were able to include our local network of preferred providers in their referral process. Third, Company Nurse helps to control medical expenses, as triage nurses often refer injured workers to urgent care clinics, rather than the ER, which saves costs and still ensures quality care. Fourth, supervisors experience ‘peace of mind’ in knowing injured employees are immediately assessed and referred for appropriate treatment, and we also experience smooth processing of claims and medical bills among the provider, insurance company, and employer.”

Company Nurse’s Injury Hotline delivers proven value. By providing injured workers with first aid and self-care guidelines, 20 to 40 percent of incoming calls are “report only” incidents and do not result in compensable claims. With appropriate care and optimal injury management, employers reduce unnecessary ER visits by as much as 300 percent. By integrating RTW coordination, many employers have reduced lost time and temporary labor costs. And with prompt, open communication, injured employees have an overwhelmingly positive experience, resulting in reduced litigation. Due to these benefits, many clients have experienced as much as a 200 percent return on investment within the first year of program implementation. These benefits have driven Company Nurse’s continued success and growth in the workers’ compensation market.

About Company Nurse
The Company Nurse Injury Hotline enables organizations to make the “Right Call” for workplace injuries. As an independent facility, our triage nurses are compassionate and objective when assessing employee injuries and medical needs. Our injury-triage process is founded on three important elements for workers’ compensation success: 1) Right Time — we respond on the Day of Injury, the earliest point at which to influence costs, outcomes, and employee satisfaction; 2) Right Care — our nurses refer employees to an appropriate level of care, whether ER, clinic or first aid; 3) Right Results — clients reap optimal savings and a return on investment, while employees benefit from a prompt, compassionate response to their workplace injuries. For more information, go to www.companynurse.com or call (888) 817-9282.

Media Contact:
Tammy Delatorre
661-775-0550

Filed Under: Facilities And Providers

Metropolitan Anesthesia Consultants Appoint Amanda O’Neal, FACHE as Chief Operating Officer

Posted on December 13, 2010 Written by Annalyn Frame

SOURCE: Metropolitan Anesthesia Consultants

Healthcare Executive to Lead Operations and Business Development at Leading Physician-Only Anesthesia Group

DALLAS, TX–(Marketwire – December 13, 2010) – Metropolitan Anesthesia Consultants (www.metroanesthesia.com), one of the largest physician-only anesthesia groups in North Texas, today announced that is has appointed Amanda O’Neal, FACHE as its Chief Operating Officer.

O’Neal will oversee business development, operations, and process improvement at the group, which has nearly 60 member physicians. Metro Anesthesia services a variety of major hospitals and hospital systems in the area, including HCA, Tenet and Baylor.

“We are pleased to have Amanda join our management team,” said Norman Rice, MD, Chairman of Metro Anesthesia. “She is a distinguished healthcare executive and active member of the community. She will help us further our mission of providing the highest quality healthcare possible.” 

O’Neal has a wealth of experience spanning physician recruitment, physician sales, marketing, corporate wellness, business planning, strategic development and more. She was previously the president and founder of Coppell-based The Brummitt Group, a boutique healthcare consulting firm. Prior to that, she held positions at Trinity Healthcare Services and HCA, Inc. O’Neal has a bachelor’s degree in business administration from Stephen F. Austin State University and a master’s degree in health administration from the University of Southern California.

O’Neal is also a Fellow of the American College of Healthcare Executives, the nation’s leading professional society for healthcare leaders. Only 7,500 healthcare executives hold this elite distinction nationwide. O’Neal is also active in her community, having recently been named chairperson of Irving Healthcare Foundation’s TexasFest gala, scheduled for next spring.

“Metro Anesthesia is one of the top physician-only anesthesia groups in the country in terms of recruiting the best doctors and providing the highest quality healthcare possible,” O’Neal said. “I’m thrilled to join their team.”

About Metropolitan Anesthesia Consultants
With nearly 60 physicians, Metropolitan Anesthesia Consultants is one of the largest physician-only anesthesia groups in North Texas. The organization prides itself on an unprecedented commitment to quality, excellence, and service. For more information, please visit http://www.metroanesthesia.com/.

Press Contact:
Erik Bratt
Defakto Group
858-737-3200
[email protected]

Click here to see all recent news from this company

Filed Under: Facilities And Providers

Radient Pharmaceuticals Signs Full Service Distribution Agreement With Naroo Ditech Inc. in Korea: Minimum Order Commitment of 3,352 Onko-Sure(R) Test…

Posted on December 13, 2010 Written by Annalyn Frame

SOURCE: Radient Pharmaceuticals Corporation

TUSTIN, CA–(Marketwire – December 13, 2010) – Through its subsidiary AMDL Diagnostics Inc., Radient Pharmaceuticals Corporation (NYSE Amex: RPC), a US-based company specializing in the research, development, and international commercialization of In Vitro Diagnostic (IVD) cancer tests, announced today it has entered into a five-year full-service distribution agreement with Naroo Ditech Inc. to expand the Company’s Onko-Sure® IVD cancer test throughout the Korean healthcare market.

Under the terms of the agreement, Naroo Ditech has committed to purchase a minimum of 3,352 Onko-Sure® test kits over the duration of the partnership. Naroo Ditech will represent RPC while obtaining regulatory clearances and providing marketing, sales, and distribution services for Onko-Sure® in diagnostic centers and clinical labs throughout the Korean market.  Marketing, sales and distribution services include developing product localization strategies; representing Radient Pharmaceuticals and its Onko-Sure® IVD cancer test at relevant healthcare conferences and events; incorporating relevant product information on the Naroo corporate website. Additionally, Naroo Ditech will provide a dedicated customer service team to respond to customer inquiries and technical questions.

RPC’s Chairman and CEO Douglas MacLellan commented on today’s news, stating, “We are extremely pleased to have finalized our sales, marketing and distribution partnership with Naroo and anticipate this agreement will significantly expand the commercialization of Onko-Sure® in the Korean market. One of Naroo’s key strategies is to market Onko-Sure® as a screening test for industrial workers at Korea’s largest manufacturers, such as Hyundai. This latest agreement adds to our expanding list of global distributors, through which RPC is working to grow product sales and revenues.”

Onko-Sure® is a simple, noninvasive, patent-pending and regulatory-approved in vitro diagnostic test that enables physicians and their patients to effectively monitor and/or detect certain types of cancers by measuring the accumulation of specific breakdown products in the blood called Fibrin and Fibrinogen Degradation Products (FDP). FDP levels rise dramatically with the progression of cancer. Onko-Sure® is approved by the US FDA for the monitoring of colorectal cancer and by Health Canada for lung cancer detection and treatment monitoring.

RPC Contact Information:
For additional information on Radient Pharmaceuticals, ADI and its portfolio of products visit the Company’s corporate website at www.radient-pharma.com. For Investor Relations information contact Kristine Szarkowitz at [email protected] or 1.206.310.5323.

About Radient Pharmaceuticals:
Headquartered in Tustin, California, Radient Pharmaceuticals is dedicated to saving lives and money for patients and global healthcare systems through the deployment of its FDA-cleared In Vitro Diagnostic Onko-Sure® Test Kits for colon-rectal cancer recurrence monitoring The company’s focus is on the discovery, development and commercialization of unique high-value diagnostic tests that help physicians answer important clinical questions related to early disease-state detection, treatment strategy and the monitoring of disease progression or recurrence. To learn more about our company, people and potentially life-saving cancer test, visit www.radient-pharma.com.

Forward Looking Statements:
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this document include certain predictions and projections that may be considered forward-looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the performance of joint venture partners, as well as other economic, competitive and technological factors involving the Company’s operations, markets, services, products, and prices. With respect to Radient Pharmaceuticals Corporation, except for the historical information contained herein, the matters discussed in this document are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements.

RPC Contact:
Kristine Szarkowitz
Director-Investor Relations
Email Contact
(Tel: ) 206.310.5323

Click here to see all recent news from this company

Filed Under: Facilities And Providers

MMRGlobal Names Sunil Singhal Executive Vice President and Adds Two Members to Board of Advisors

Posted on December 13, 2010 Written by Annalyn Frame

SOURCE: MMRGlobal, Inc.

LOS ANGELES, CA–(Marketwire – December 13, 2010) –  MMRGlobal, Inc. (OTCBB: MMRF) (“MMR”) today announced that Sunil Singhil has been named Executive Vice President and a member of the Executive Committee, succeeding Rich Teich, who will focus on the sales, marketing and installation support for MMRPro and MMRPatientView, the Company’s professional health IT products for physicians, small hospitals and healthcare professionals. Mr. Singhal was introduced to the Company by Nihilent Technologies, where he was Co-founder and served as Chief Operating Officer of North America. In addition, Michael J. Finley, Vice President, Worldwide Carrier Relations at Qualcomm, and John R. Seitz, CEO of Spalding Surgical Center of Beverly Hills, have agreed to join MMRGlobal’s Board of Advisors. 

Robert H. Lorsch, MMRGlobal Chairman and Chief Executive Officer, said, “Since September of this year, Sunil has been working alongside Rich and I overseeing the integration and development of MMRGlobal’s MyMedicalRecords.com Personal Health Record, the MyEsafeDepositBox.com online vault, and the MMRPro suite of professional products and services. In his new position as Executive Vice President, Sunil will also work with me and Ingrid Safranek, MMR’s Chief Financial Officer, on the day-to-day management of the Company.”

Mike Finley, who Lorsch has known for nearly 18 years since he was a President of Verizon Wireless, has been advising the Company since its initial meetings with Sprint Nextel in Kansas City, where he was President of the West Region and Senior Vice President of Sprint Corporation. A widely respected executive in the telecommunications and wireless industry, necessary to the MMR operating system and MMRGlobal’s future growth in wireless, Mr. Finley’s success in selling wireless technologies to consumers is a timely addition as the Company goes deeper into mobile health opportunities for MyMedicalRecords and MMRPro. With the addition of John Seitz to the Board of Advisors, management has the expertise of a recognized leader in the Ambulatory Surgical Center industry. Mr. Seitz heads one of the most advanced surgical centers in the U.S. and will advise on the Company’s strategy for sales of MMRPro into surgery centers and other healthcare specialty groups.

In addition to the new appointments, MMRGlobal has increased its presence at Associated Television International’s headquarter building in Los Angeles, adding an additional 3,000 sq. ft. for sales training, outbound telesales, and a videoconferencing center.

Management

Sunil Singhal: Mr. Singhal, 55, has over 25 years experience in the IT products and services industry where he is recognized for strategically implementing innovative technologies. He has expertise in all facets of the IT products and services business, including executive management, information strategy planning, cross-border operations, business development, sales and marketing, R&D, project management, and mergers and acquisitions. From 2005 until 2010, he was head of North American Sales in the Energy, Resources, and Utilities industry for Tata Consultancy Services (TCS). Prior to that, from 2001 to 2005, he was Co-founder and Chief Operating Officer, North America of Nihilent Technologies, which is MMRGlobal’s technology partner.

Mr. Singhal started his IT services career with Tata Consultancy Services in 1979 and was involved in products and tools development, project management, and business development until 1991. From 1991 to 2001, he held a series of senior technical, business development and executive management positions with entrepreneurial companies. These included International Informatics Solutions (now Xansa) as Technical Director and Member of the Board; IMRglobal Corp. (now CGI, Inc.) as Vice President of Southwest Region and Vice President of Northeast Region; and Hexaware Technologies, Inc. as Senior Vice President for Business Development. Throughout his career, Mr. Singhal has established long-term business relationships with clients in North America, the United Kingdom, Europe, India and Singapore.

Mr. Singhal holds a Bachelor’s degree in Electronics and Communication Engineering from the University of Roorkee (now IIT, Roorkee) and a Masters degree in Digital Electronics from NUFFIC/PII, Eindhoven in the Netherlands.

Board of Advisors

Mike Finley: Prior to his current position as Vice President, Worldwide Carrier Relations for Qualcomm, Mr. Finley was President of the West Region for Sprint Nextel from 2006 to 2008 and a Senior Vice President of Sprint Corporation. He joined Nextel in 2002 as Area Vice President of Southern California and was promoted to Senior Vice President of General Business for the U.S. following the Sprint Nextel merger. Before joining Nextel, he was a Senior Vice President of Wingcast, a JV between Ford Motor Company and Qualcomm which developed telematic products for Ford vehicles. From 1993 to 2001, Mr. Finley served as President of Verizon Wireless in Southern California, Vice President and General Manager in Sacramento and was Vice President of Sales in Ohio for Airtouch Cellular. Prior to joining Airtouch, he held positions with Cellular One and McCaw Cellular. He began his career in communications in 1985 as a Co-founder of Celluland, a national franchise which created an alternative distribution approach in advance of consumer marketing of wireless products. 

John Seitz: Mr. Seitz is Chief Executive Officer of Ambulatory Surgical Group (ASG), an Ambulatory Surgical Center (ASC) development and management company headquartered in El Segundo, California. In his leadership role, he oversees business development and operational and financial management of all ASG surgery centers, and his financial management skills are widely sought throughout the industry. For over 25 years, Mr. Seitz has focused on healthcare, gaining an extensive network of contacts and earning the respect of physicians and industry executives as a developer and manager of ASC projects. Prior to Ambulatory Surgical Group, he has been a founder and either the CEO or president of three successful start-up companies in the healthcare industry. Most recently, he was one of the founders and President of Surgem, LLC, where he was responsible for building the ASC company from start-up to success in less than three years. During his time at Surgem, he recruited the management team, directed the development and operation of eight ASC projects and was responsible for the acquisition and turnaround of an underperforming center. Prior to Surgem, he was founder and CEO of Cornerstone Physicians, a nationally recognized medical practice management company.

About MMRGlobal, Inc.

MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. (MMR), provides secure and easy-to-use online Personal Health Records (PHRs) and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. The MyMedicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user’s account. MMRGlobal’s professional offering, MMRPro, is designed to give physicians’ offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. MMR is also an integrated service provider on Google Health. To learn more about MMRGlobal, Inc. and its products, visit www.mmrglobal.com.

Forward-Looking Statements

Any statements contained in this press release that refer to future events or other non-historical matters are forward-looking statements, and some can be identified by the use of words (and their derivations) such as “need,” “possibility,” “offer,” “development,” “if,” “negotiate,” “when,” “begun,” “believe,” “achieve,” “will,” “estimate,” “expect,” “maintain,” “plan,” “help” and “continue,” or the negative of such terms and other comparable terminology. MMRGlobal, Inc. disclaims any intent or obligation to revise or update any forward-looking statements. These forward-looking statements are based on MMRGlobal, Inc.’s reasonable expectations as of the date of this press release and are subject to risks and uncertainties that could cause actual results to differ materially from current expectations. The information discussed in this release is subject to various risks and uncertainties related but not limited to changes in MMRGlobal, Inc.’s business prospects, its results of operations or financial condition, government regulation and changes in healthcare initiatives, and such other risks and uncertainties as detailed from time to time in MMRGlobal, Inc.’s public filings with the U.S. Securities and Exchange Commission.

CONTACT:
Bobbie Volman
MMRGlobal, Inc.
(310) 476-7002, Ext. 7015
[email protected]

Michael Selsman
Public Communications Co.
(310) 553-5732
[email protected]

Click here to see all recent news from this company

Filed Under: Facilities And Providers

Zweena(R) Revolutionizes Personal Health Records With New Internet Service for Individuals and Their Families

Posted on December 13, 2010 Written by Annalyn Frame

SOURCE: Zweena

Partnered With Microsoft HealthVault®, Zweena Eliminates the Complexity of Creating and Managing a PHR for Use in Self-Care, Family Care, and Protection Against Medical Errors

SKILLMAN, NJ–(Marketwire – December 13, 2010) – Zweena® today launched its revolutionary new Personal Health Record (PHR) web service, featuring a proven proprietary platform that eliminates the complexity of creating and managing an online health record. Partnered with Microsoft HealthVault®, Zweena enables consumers to create and maintain a personally controlled patient health record for meaningful use in self-care, care of family members, and to share medical records directly with healthcare providers, via the Internet. Zweena’s innovative platform collects medical records on behalf of individuals, creates a PHR based on the Continuous Care Record (CCR) guidelines outlined by the American Academy of Family Practice, then stores both scanned and discreet data within the individual’s own secure Personal Health Community (PHC) for sharing with family members, and directly with providers.

“Eighty-six percent of Americans or higher say that PHRs could help them avoid duplicated tests, keep doctors informed, check the accuracy of medical records, and track personal health expenses, yet only seven percent use PHRs today, due to the complexity in creating and maintaining a PHR with existing services,” said John Phelan, CEO of Zweena. “Recognizing the urgency and need for consumers to have accurate and current PHRs, Zweena developed a revolutionary electronic health record system that makes personal digital health records easy to set up, keep current, and share in a secure network for use in self-care and care of family members.”

About Zweena
Zweena®, taken from the Moroccan name meaning “beautiful,” connects individuals and their family members to the medical community of doctors and providers they rely on to manage and maintain their health. Zweena powers the leading Internet-based platform for creating and managing a Personal Health Record (PHR). Partnered with Microsoft HealthVault®, Zweena transforms paper medical records into scanned and organized discreet data files, eliminating the complexity of creating and managing a PHR on one’s own. The Zweena Personal Health Record is accurate, current, and can be used in self-care, the care of family members, and shared with healthcare providers via an individual’s secure Personal Health Community (PHC), anywhere in the world. For information on Zweena, visit: www.zweenahealth.com.

Media Contacts:
Mark Hall
EGOEAST Inc.
Email Contact
609-477-3475

Click here to see all recent news from this company

Filed Under: Facilities And Providers

DentalPlans.com Launches Blue Cross and Blue Shield of Florida FamilyBlue Discount Plan

Posted on December 13, 2010 Written by Annalyn Frame

SOURCE: DentalPlans.com

Leading Dental Plan and Healthcare Provider to Offer Savings on Dental Care and More

PLANTATION, FL–(Marketwire – December 13, 2010) – DentalPlans.com, the definitive source of discount dental plans in the United States, continues to grow as they announce the addition of the Blue Cross and Blue Shield of Florida FamilyBlue Discount Plan. The plan joins the already extensive list of 30+ affordable regional and national dental plans on DentalPlans.com. 

The Blue Cross and Blue Shield of Florida FamilyBlue Discount Plan grants members access to a network of providers across the state of Florida, each agreeing to offer their dental services at a discount of 10% to 50%. Plan members will find sizeable savings on everything from cleanings and checkups, to root canals, braces, crowns and some cosmetic procedures. For the first time, individuals and families can join the FamilyBlue Discount Plan for an entire year on DentalPlans.com and receive 3 additional months of membership for free. These turnkey plans start at $134.95 a year for individuals and $179.95 a year for adults.

“Blue Cross and Blue Shield of Florida is one of the most trusted and recognizable healthcare providers in the country,” says Buddy Johnson, CEO of DentalPlans.com. “We’re excited to announce this addition to our diverse offering of discount dental plans, so we can make dental care more affordable and accessible to people throughout the state of Florida.”

The Blue Cross and Blue Shield of Florida FamilyBlue Discount Plan does not have health restrictions or annual limits, and can be used as often as needed. In addition to dental care, the plan also provides discounts on other health services such as vision care, hearing care, diabetic supplies, chiropractic services and prescription drugs. A 24-Hour NurseLine and vitamins (including beauty, wellness and pet products) are also offered at a discount for the convenience of its members.

Interviews with DentalPlans.com representatives and network practitioners are available. For editorial inquiries, please contact Kelly Downey of Shamin Abas Public Relations at 561.366.1226 or [email protected].

About DentalPlans.com (www.DentalPlans.com)

DentalPlans.com is dedicated to improving oral health nationwide by making quality dental care affordable and accessible to everyone. DentalPlans.com proudly offers the freedom to choose from an extensive selection of discount dental plans designed to save members money on their dental care needs. With more than 40 years of experience in the dental industry, their devoted team quickly transformed DentalPlans.com into a trusted industry leader and the largest online provider of discount dental plans. Since 1999, DentalPlans.com has offered great value and convenience with an extensive choice of money-saving discount dental plans in one user-friendly website.

MEDIA CONTACT:
Kelly Downey
Shamin Abas Public Relations
561.366.1226

Click here to see all recent news from this company

Filed Under: Facilities And Providers

FONAR UPRIGHT MRI Customer Wins Jury Decision in Federal Court for Antitrust Lawsuit Versus CareCore National

Posted on December 13, 2010 Written by Annalyn Frame

SOURCE: FONAR Corporation

MELVILLE, NY–(Marketwire – December 13, 2010) – FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning™, announced today that a provider of outpatient diagnostic services (a FONAR customer) and several Stand-Up MRI diagnostic imaging professional corporations (PCs) received a jury verdict in their favor in an anti-trust lawsuit against CareCore National, LLC, a radiology benefits management (RBM) company (www.carecorenational.com).

This antitrust lawsuit involved CareCore National’s exclusion of the plaintiffs, all of them providers of MRI services using Stand-Up MRI scanners (FONAR UPRIGHT® Multi-Position™ MRIs), from utilization by its member subscribers. CareCore Radiology, a division of CareCore National, covers more than 30 million member subscribers in all 50 states. The diagnostic service provider and the PCs were represented by Constantine Cannon LLP, New York, NY, (www.constantinecannon.com). 

After more than a two-week trial, the verdict was reached November 30, 2010 in the U.S. District Court for the Eastern District of New York. The case is Stand-Up MRI v. CareCore National, E.D.N.Y. Case No: 08 Civ. 2954 (LDW) (ETB). The eight members of the jury were unanimous in their decision and awarded over $11 million in damages to the diagnostic service provider and the PCs in the case, which are to be trebled by law. The total judgment with costs and attorney fees is expected to be close to $40 million.

In a press release, (http://www.prnewswire.com/news-releases/constantine-cannon-attorneys-win-important-healthcare-antitrust-jury-trial-against-carecore-national-llc-111128319.html) lead Constantine Cannon trial attorney Matthew Cantor said: “This verdict is not just important for my clients, but for patients everywhere. The evidence in this case showed that even CareCore considered the Upright MRI to be medically necessary and that, nonetheless, CareCore and its owners denied patients the ability to benefit from these important diagnostic procedures. The actions of benefits managers (RBMs) that are owned and controlled by physicians, like CareCore, must be scrutinized to ensure that patient welfare is not compromised. Constantine Cannon expects that the defendants will attempt to overturn the jury award either in post-trial motion practice or on appeal. If that occurs, Constantine Cannon will vigorously defend the decision of the jury.”

“The jury found that CareCore, in league with New York-area radiologists and radiology practices that owned and/or governed CareCore, conspired to unreasonably restrain trade in the market for commercially-insured outpatient radiology procedures. The jury also found that these restraints harmed the plaintiffs — several New York radiology practices and their medical management company — that offer unique and medically necessary Upright MRI services. The Upright MRI is the only MRI that can scan patients in the weight-bearing positions that patients actually feel their pain. By doing so, Upright MRIs diagnose patient ailments, including those related to the spine, that no other MRI can,” said Cantor.

Raymond Damadian, president and founder of FONAR said, “We are pleased that the Federal Court and Jury understands the medical necessity of the FONAR UPRIGHT® Multi-Position™ MRI aka STAND-UP® MRI. This is important for FONAR, its customers, future customers and particularly the patients who need the UPRIGHT® MRI so they can be correctly diagnosed and not be given the wrong treatment which often involves surgery. We expect this to help those patients across our nation who have been previously denied these critical examinations by the RBMs.”

“FONAR’s UPRIGHT® MR technology is vital to patient needs nationwide,” said Dr. Damadian. “Back pain is the second most common reason for visiting the doctor’s office after the common cold. Close to one million spine surgeries are performed each year, but the outcomes are not good with a failure rate that varies from 10% to 40% depending on the reported study (1). Alf Nachemson, MD refers to the saddest group of these patients, those who have undergone 4, 5, or 6 spine surgeries as “multiply operated surgical cripples” (2). The surgical failure is commonly the result of operating on the wrong spinal segment (i.e. not the one responsible for the patient’s pain). This occurs because the origin of the pain is often attributed to the wrong degenerative change in the spine when the patient is imaged on a recumbent-only MRI. Degenerative changes in the adult spine are frequently multiple in number. The suspected pain generating anatomy is conventionally identified from recumbent (conventional) MRI images while the patient’s pain often occurs only when the patient is upright and when the pathology generating it is visible only when the patient is upright and fully weight-loaded.”

Dr. Damadian continued, “The FONAR UPRIGHT® Multi-Position™ MRI enables the patient to place himself in the position that generates his pain so that an MRI picture can be taken in the same position that generated the patient’s pain. Correctly identifying the pain generating pathology markedly improves patient surgical outcomes. In addition, it enables the surgeon to see ALL the pathology he has to address, not just the single position non-weight-bearing image provided by the conventional MRI. This enables the surgeon to see the full extent to which the disk herniation of his patient increases when he/she flexes or extends, or the extent to which the patient’s vertebra is sliding back and forth with body position and generating pain. Approximately 1 million spine surgeries are performed in the U.S. each year and technology to improve the surgical outcomes for these patients is a serious need.”

“In addition, there are a wide range of other needs that patients have for FONAR’s UPRIGHT® Multi-Position™ MR imaging technology,” said Dr. Damadian. “Patients who have been hospitalized, for example, with congestive heart failure, cannot lie down. In the absence of UPRIGHT ® MRI these patients are unable to receive MRI examinations when they are needed.”

“Patients with scoliosis, which most commonly arises for the first time in young adolescent girls, have been reported by the National Cancer Institute (3) to experience a 70% higher incidence of breast cancer as adults than the non-scoliotic population. The increased incidence is attributed to the multiple annual chest x-rays (2-3 times per year) needed to monitor the child’s scoliosis until adulthood in order to assure satisfactory treatment.” Dr. Damadian added, “the FONAR UPRIGHT® MRI provides the same necessary vertebral angle (“Cobb angle”) measurements as the x-ray (plus the needed measurements of vertebra rotation not supplied by x-ray), thereby avoiding the annual radiations of the x-ray procedure and eliminating the danger of subsequent adult breast cancer.”

“Women patients, for example, as a result of the inherent trauma of childbirth to their pelvic floor anatomy, will commonly suffer the consequences of PFD (pelvic floor dystrophy) later in life. The symptoms of PFD are cystic prolapse (“falling urinary bladder”) and its chronic cystitis symptoms of urinary frequency, burning on urination, fever, and if unaddressed, chronic kidney inflammation (pyclonephritis). The patient must be upright to see it. It commonly returns to its normal position when the patient is recumbent and therefore is not diagnosed by the patient’s physician who examines her in the recumbent position. It affects 10 million women. The UPRIGHT® MRI readily visualizes the fallen bladder when these patients are upright, so that the surgeon has full image visualization of the anatomy that has to be repaired.

“Another serious present need for the FONAR UPRIGHT® Multi-Position™ MRI is the rising body of patients who are sustaining dislocations of the cervical spine from automobile collision whiplash injuries of the head and neck. The UPRIGHT® MRI is needed to assess the extent to which the brain has been dislocated [descent of the tonsils of the cerebellum] into the opening in the bottom of the skull (foramen magnum). This critical assessment of the extent of brain herniation into the opening at the base of the skull (cerebellar tonsil ectopia, or CTE) can only be determined with the patient in the upright position so that the surgical repair of this herniation and the patient’s “drop attacks” can be eliminated. (4)”

(1) The Failed Spine, M. Szpalski and R. Gunzburg, eds., Lippincott Williams & Wilkins, 2005, p. 123.
(2) Alf L. Nachemson, MD, “The Lumbar Spine An Orthopaedic Challenge”, Spine, Vol. 1, Number 1, March 1976, p. 65.
(3) National Cancer Institute, “Scientists Find Link Between Pre-1970’s Diagnostic X-rays for Scoliosis and Breast Cancer Mortality,” www.cancer.gov, 8/15/2000. “Breast Cancer Mortality  After Diagnostic Radiography: Findings from the U.S. Scoliosis Cohort Study”, Michele Morin Doody, et al., Spine, Aug. 15, 2000, Vol. 25, No. 16.
(4) Michael D. Freeman, et al., Brain Injury, July 2010:24(7-8):988-994.

About Constantine Cannon LLP

Constantine Cannon LLP represented the plaintiffs in the case. They have deep expertise in practice areas that include antitrust and complex commercial litigation, government relations, employment matters, securities and e-discovery. With offices in New York, NY and Washington, DC, the firm’s antitrust practice is among the largest in the nation, with more than 30 attorneys representing both plaintiffs and defendants in complex antitrust litigation.

For investor and other information visit: www.fonar.com.

UPRIGHT® and STAND-UP® are registered trademarks and The Inventor of MR Scanning™, Full Range of Motion™, pMRI™, Dynamic™, Multi-Position™, True Flow™, The Proof is in the Picture™, Spondylography™ Spondylometry™ and Upright Radiology™ are trademarks of FONAR Corporation.

This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company’s financial results may be found in the company’s filings with the Securities and Exchange Commission.

Filed Under: Facilities And Providers

American Diabetes Association Applauds Two-Year Re-Authorization of Special Diabetes Program

Posted on December 9, 2010 Written by Annalyn Frame

SOURCE: American Diabetes Association

ALEXANDRIA, VA–(Marketwire – December 9, 2010) – The American Diabetes Association®, the nation’s leading voluntary health organization in the fight to Stop Diabetes®, praises Congress for reauthorizing the Special Diabetes Program. The renewal, which was part of the Medicare and Medicaid Extenders Act of 2010, will ensure the Special Diabetes Program for Indians (SDPI) and the Special Diabetes Programs for Type 1 Diabetes (SDP-Type1) continue through September 2013. The measure will provide $150 million in funding per year to each program. Nearly 24 million Americans are living with diabetes and another 57 million have prediabetes. Recently, the Centers for Disease Control and Prevention (CDC) released a report stating that if current trends continue, one in three Americans will have diabetes by the year 2050. Diabetes is among the leading causes of death by disease in the United States. It is a leading cause of heart disease, stroke, blindness, kidney disease, and amputation.

SDPI provides prevention, education and treatment programs in Native American communities. American Indians and Alaska Natives have the highest age-adjusted prevalence of diabetes among all U.S. racial and ethnic groups, where diabetes is four to eight times more common than in the general population. Studies have demonstrated that SDPI’s prevention and treatment efforts have contributed to significant reductions in diabetes complications in these targeted populations.

“We applaud the extension of the Special Diabetes Programs,” said Gale Marshall, Chair, American Diabetes Association’s Awakening the Spirit Native American initiative. “The Special Diabetes Program for Indians provides for more than 450 community-directed programs, allowing local tribes and health programs to set priorities that meet their needs, including prevention activities or treatment. Because of these education and treatment programs, the American Indian and Alaskan Native communities have stories of hope and progress in facing the battle against diabetes.” 

The Special Diabetes Programs for Type 1 Diabetes provides funding for groundbreaking type 1 diabetes research. Clinical research supported by this program has demonstrated tangible results — from delaying the full onset of type 1 diabetes in newly diagnosed patients to gaining insight on the underlying causes of diabetes and halting or reversing costly complications such as diabetic eye disease.

“The Special Diabetes Programs for Type 1 Diabetes is a vital federal effort that is bringing us closer to a cure for this epidemic,” said Janel Wright, National Chair, Advocacy Committee, American Diabetes Association. “This cost-effective program provides crucial funding for research and results in real advances for people living with type 1 diabetes.”

About The American Diabetes Association
The American Diabetes Association is leading the fight to stop diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.

Contact:
Lauren Gleason
(703) 549-1500 Ext. 2622
[email protected]

id=”nav_links”>

Filed Under: Facilities And Providers

Fresh Start Private Naltrexone Implant Procedure Shows Excellent Potential for Reduction in Alcoholism

Posted on December 9, 2010 Written by Annalyn Frame

SOURCE: Fresh Start Private Management Inc.

Naltrexone Reduces the Number of Occasions During Which a Person Is Likely to Drink

LOS ANGELES, CA–(Marketwire – December 9, 2010) – Fresh Start Private (OTCQX: CEYY) (PINKSHEETS: CEYY), a leader in the alcohol treatment and rehabilitation industry, provided data today showing that Naltrexone is effective in the treatment of alcoholism.

According to published results in the Oxford Journals, research indicated that “Naltrexone is superior to placebo. Subjects treated with Naltrexone experience significantly fewer episodes of relapse, and significantly more remain abstinent when compared to placebo-treated subjects {risk difference of relapse rates = -14% [95% confidence interval (CI): -23%, -5%]; and risk difference of abstinence rates = 10% (95% CI: 4%, 16%)} after 12 weeks of treatment. The Naltrexone-treated subjects also consume significantly less alcohol over the study period than do placebo-treated subjects.” See http://alcalc.oxfordjournals.org/content/36/6/544.full for the complete results of the study.

A study by Joseph R. Volpicelli, MD, PhD; Arthur I. Alterman, PhD; Motoi Hayashida, MD, ScD; Charles P. O’Brien, MD, PhD, yielded other significant findings as follows:

“Seventy male alcohol-dependent patients participated in a 12-week, double-blind, placebo-controlled trial of Naltrexone hydrochloride (50 mg/d) as an adjunct to treatment following alcohol detoxification. Subjects taking Naltrexone reported significantly less alcohol craving and days in which any alcohol was consumed. During the 12-week study, only 23% of the Naltrexone-treated subjects met the criteria for a relapse, whereas 54.3% of the placebo-treated subjects relapsed. The primary effect of Naltrexone was seen in patients who drank any alcohol while attending outpatient treatment. Nineteen (95%) of the 20 placebo-treated patients relapsed after they sampled alcohol, while only eight (50%) of 16 Naltrexone-treated patients exposed to alcohol met relapse criteria. These results suggest that Naltrexone may be a safe and effective adjunct to treatment in alcohol-dependent subjects, particularly in preventing alcohol relapse.”

Fresh Start Private (FSP) is the only alcohol treatment program to offer a single-administration, licensed long-acting, Naltrexone implant procedure. Naltrexone has been approved for use by the FDA within the United States for the treatment of alcohol.

Trained medical doctors insert a specially formulated, biodegradable Naltrexone implant just beneath the skin below the patient’s lower abdominal area. The procedure is rapid and requires only local anaesthetic.

FSPs revolutionary procedure works instantly to block the receptors in the brain that crave alcohol. This one-time treatment is affordable and so fast a patient can be back to work the very next day, free from the physical cravings for alcohol.

About Fresh Start Private

Fresh Start Private is an alcohol addiction, alcohol withdrawal, alcohol abuse treatment and alcohol detox rehabilitation company on the leading edge of the alcohol addiction treatment. The Company has licensed a highly effective treatment delivers target therapeutic levels of Naltrexone that significantly reduce patients’ cravings for alcohol. Please visit www.freshstartprivate.com

Statements in this press release may be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations, estimates and projections about the company’s business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in Fresh Start filings with the Securities and Exchange Commission.

Contact
Tom Kennedy
Phone: 949.209.8964
Email Contact

Filed Under: Facilities And Providers

The Children’s Medical Center of Dayton Partners With Medicity for Health Information Exchange in Ohio’s Miami Valley

Posted on December 9, 2010 Written by Annalyn Frame

SOURCE: Medicity

Bidirectional Exchange Will Connect Hospital Systems, Physician EHRs and Allied Care Providers to Improve Care Delivery

SALT LAKE CITY, UT–(Marketwire – December 9, 2010) –  The Children’s Medical Center of Dayton (Dayton Children’s), a not-for-profit, freestanding children’s hospital serving 20 counties in Ohio and Eastern Indiana, has selected Medicity to power bidirectional health information exchange (HIE) between the medical center, affiliated physicians and other partners in its healthcare community.

Dayton Children’s will implement Medicity’s Novo Grid infrastructure — patented technology for connecting care teams and integrating with electronic health records (EHRs) — to distribute results, reports, and face sheets from the hospital’s Epic clinical systems and McKesson registration systems to community providers. The same Grid infrastructure will power laboratory and radiology orders back to the hospital.

“Our partnership with Medicity enables us to meet the HIE needs of Dayton providers while addressing our hospital’s unique business objectives,” said Beth Fredette, Dayton Children’s CIO. “By sponsoring the secure flow of health information in our community, we aim to improve clinical workflow, enhance patient care and improve affinity with our affiliated physicians by supporting their efforts to achieve meaningful use requirements.”

“The Grid enables secure electronic exchange regardless of which EHR a physician practice has adopted or whether the practice is paper-based,” said Kipp Lassetter, MD, Medicity CEO, “which means that Dayton Children’s now has a single solution that adapts to a wide variety of practice needs. Significantly, the Grid also provides the flexibility and control for the hospital to connect with state and regional HIE initiatives as they come along.”

About The Children’s Medical Center of Dayton
The Children’s Medical Center of Dayton is the region’s only medical facility dedicated to children. Consistently recognized as one of the country’s best pediatric hospitals, Dayton Children’s provides medical treatment, advice and information for children and families from 20 Ohio counties and eastern Indiana. Dayton Children’s accreditation by the Joint Commission on Accreditation of Healthcare Organizations ensures the regions’ infants, children and teens receive excellent pediatric care. For more children’s health and safety information, visit our web site at www.childrensdayton.org.

About Medicity
Medicity, the industry standard for health information exchange (HIE), is the leading innovator and largest provider of HIE technology — with more than 700 hospitals and 250,000 physicians in its connected ecosystem. Medicity’s solutions empower hospitals, physicians and HIEs with secure access to and exchange of health information — improving the quality and efficiency of patient care locally, regionally and nationally. For more information, please visit us or follow us on Twitter.

Contact:
Amendola Communications for Medicity
Janet Cabibbo
480-664-8412 ext. 15
[email protected]

Moira Alter
Marketing Manager, Dayton Children’s
937-641-3618
[email protected]

Click here to see all recent news from this company

Filed Under: Facilities And Providers

Marathon Health Engagement Rates Exceed Prediction for Health Improvement

Posted on December 9, 2010 Written by Annalyn Frame

SOURCE: Marathon Health

BURLINGTON, VT–(Marketwire – December 9, 2010) – Marathon Health today announced that health program engagement rates achieved for Accellent, Inc exceeded prediction by 27%. Marathon Health achieved a 97% engagement rate of the target population identified in March 2009 as being at high risk for a chronic condition or who had an existing chronic condition. The Marathon Health definition of engagement is any person who has met with the nurse health coach and selected a risk- or condition-related goal to work on with health coaching as appropriate.

Accellent, a leading supplier of supply chain solutions to the medical device industry, offers its employees face-to-face health assessments and health risk reduction coaching at their 15 US locations. Marathon Health provides these services with traveling nurses who visit Accellent sites at regularly scheduled intervals. Marathon Health also provides onsite health services at three of Accellent’s sites.

“Achieving this rate of engagement with a distributed workforce can be attributed to several factors,” said Tricia McCall, Accellent Vice President of Human Resources. “We have strong program champions at the local level to coordinate the activities. We offer an incentive program to get people involved with the screenings and assessments. And through Marathon Health, we provide high-quality coaching and outreach programs. Together, these factors combine to create the level of involvement we are seeing. This effort is one more way we are staying true to our company vision of ‘Helping People Live Better Lives’.”

The focus on engaging individuals with health risk factors has played an important role in the -3% medical trend experience at Accellent.

“It is well documented that individuals with high risk factors, such as hypertension, smoking, and obesity, will consume healthcare resources at two — five times the rate of a healthy person,” said David Demers, MPH, director of strategic planning at Marathon Health. “And while the numbers speak volumes, the real success is found in the hundreds of individual stories of employees who have improved their health. That is what we are most proud of at Marathon Health.”

About Accellent
Accellent provides fully integrated outsourced manufacturing and engineering services to the medical device industry in the cardiology, endoscopy and orthopaedic markets. Accellent has broad capabilities in design and engineering services, precision component fabrication, finished device assembly and complete supply chain management solutions. These capabilities enhance our customers’ speed to market and their return on investment by allowing them to focus their internal resources more efficiently. For more information, please visit www.accellent.com .

About Marathon Health
Marathon Health of Colchester, VT, offers a proven solution for helping employers reduce the total cost of healthcare. The Marathon Health approach integrates the best practices of onsite primary care, health assessment with risk identification, coaching and advocacy, and disease management for high cost chronic conditions. Marathon Health supports its unique model with an eHealth Portal delivering medical content, interactive diet and fitness tools, a personal health record, and an electronic medical record to manage care. For more information, please visit www.marathon-health.com.

Contact:
Tracey Moran
802-857-0459
Email Contact

Click here to see all recent news from this company

Filed Under: Facilities And Providers

InoLife Technologies, Inc. Retains John O’Maley and Associates to Launch Aggressive Retail Sales & Marketing Program for Company’s DNA-Based…

Posted on December 9, 2010 Written by Annalyn Frame

SOURCE: InoLife Technologies Inc.

30 Years of Experience and 40-Plus Successful Product Launchings Greatly Contributed to the Decision

RALEIGH, NC–(Marketwire – December 9, 2010) – InoLife Technologies, Inc. (OTCBB: INOL), a service based healthcare products development, integration and marketing Company, announced today that it has retained John O’Maley and Associates to manage its retail sales & marketing program and aggressively place the Company’s current and future DNA-based products into the consumer market.

John O’Maley and Associates (JOA) provide over 30 years of experience in successfully launching over 40 consumer products into nearly every trade channel of the market. This company has a long-standing and trusted reputation in the retail industry in providing world-class sales presentations on products that result in significant sales and brand awareness.

John O’Maley, President of JOA, contributes his success from his training in sales and marketing, advertising and business development at Proctor & Gamble. That experience has proven to be instrumental in generating outstanding results for his clients. JOA also uses a proven national broker network that consists of over 30 key senior account sales executives who were trained in fortune 500 companies. This ensures continuity and excellent national coverage. For more information on JOA visit www.omaley.com

InoLife has considered many companies to use for this important aspect for the success in placing its current and future DNA-Based products into the consumer market. Management feels that John O’Maley and Associates has the experience and proven success record to get the job done. We look forward to working with John’s company.

About InoLife Technologies, Inc.
InoLife is poised to become one of the premier U.S. marketers of state-of-the-art DNA-based test products. Positioned for growth and success in a burgeoning market, InoLife Technologies, www.inolifetech.com, is primarily focused on products, services and solutions that will enable state-of-the-art healthcare for today and the future for a diverse base of customers and end users. The Company’s mission is to identify, develop, integrate and bring to market innovative healthcare-based products and services that provide timely and practical solutions. The primary products and services that InoLife is currently addressing focuses upon those specific products and services that provide key solutions through the innovative use of specific DNA testing and Genetic analysis systems.

The principal customers of InoLife’s products and services are healthcare providers, physicians, practitioners, hospitals and outpatient facilities. InoLife will be marketing and distributing its products through traditional distribution channels. Additionally InoLife has developed certain products that can be sold directly to consumers and has created specific programs to reach those customers including e-commerce, direct sales, healthcare providers, pharmacies, distributors, retail sellers and specialty retailers.

Forward-Looking Statements
Safe Harbor Statement under the Private securities Litigation Reform Act of 1995: The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements including, but not limited to, certain delays beyond the Company’s control with respect to market acceptance of new technologies, products and services, delays in testing and evaluation of products and services, and other risks detailed from time to time in the Company’s filings with the Securities and Exchange Commission.

Filed Under: Facilities And Providers

Manchester Manor Health Care Center Distinguished With Highest Level National Award

Posted on December 9, 2010 Written by Annalyn Frame

SOURCE: Manchester Manor Health Care Center

Achievement in Excellence Awarded for Exemplary Delivery of Quality Long Term Care

MANCHESTER, CT–(Marketwire – December 9, 2010) – Manchester Manor Health Care Center has been recognized as a 2010 recipient of the National Quality Award at the level of Gold – Excellence in Quality presented by the American Health Care Association/National Centers for Assisted Living (AHCA/NCAL), a Washington D.C. based trade organization with approximately 11,000 nursing facility members nationwide. Manchester Manor is the only 2010 recipient of this distinguished national award. Over the 15 years of the Quality Award program, only 4 companies, owning 10 facilities, have ever received an award at this level. The award was formally presented to Manchester Manor during AHCA’s 61st Annual Convention and Exposition, October 10-13, 2010 in Long Beach, CA.

“The staff and leadership of Manchester Manor Health Care Center have demonstrated that they can sustain a high level of performance across a broad spectrum of services, and have set themselves apart as a health care organization of the highest distinction,” stated Bruce Yarwood, President and CEO of AHCA. “We applaud this outstanding achievement that honors their commitment to a rigorous journey of continuous improvement.”

Implemented by AHCA/NCAL in 1996, the National Quality Award Program is based on the core values and criteria of the Malcolm Baldrige National Quality Award Program. It provides a pathway for providers of long term and post-acute care services to journey towards performance excellence. Applicants for the prestigious Gold – Excellence in Quality award demonstrate by approach, deployment and consistency of results that they are achieving high levels of performance in health care, customer satisfaction, market, workforce, process and leadership outcomes over time. At the Gold level, applicants must successfully address the Malcolm Baldrige Program’s Health Care Criteria for Performance Excellence. Gold applications are reviewed by teams of Master Examiners with extensive qualifications and special training to qualify as judges. A ten member Board of Overseers provides oversight of the award program.

“No one knows better than the staff at Manchester Manor that their quality journey never ends, but this award level is a significant achievement,” stated Bernie Dana, Chair, AHCA/NCAL National Quality Award Board of Overseers. “Clearly Manchester Manor is one of the very best long term care providers in the entire nation.”

Manchester Manor Health Care Center previously received the Silver – Achievement in Quality Award (2008) and the Bronze – Commitment to Quality Award (2007).

Contact:
Mary Ellen Gaudette
Administrator
Email Contact
385 West Center St.
Manchester, CT
Tel. 860-533-2532
Fax. 860-645-0841

Click here to see all recent news from this company

Filed Under: Facilities And Providers

What 2010 Planning Will Mean for Pharma and Biotech in 2011

Posted on December 9, 2010 Written by Annalyn Frame

SOURCE: Cutting Edge Information

Top Research Topics in 2010 Point Spotlight on Where Companies Will Be Taking Action Next Year and Beyond, Says Management Consulting Firm Cutting Edge Information

RESEARCH TRIANGLE PARK, NC–(Marketwire – December 9, 2010) – As many companies put the finishing touches on their 2011 Action Plans, the pharmaceutical and biotechnology sectors are looking to create opportunities from the challenges of recent years.

Cutting Edge Information, Inc. analyzed what issues its clients have studied most closely in 2010 and the resulting decisions and strategies they are likely to implement in 2011. “The popularity of each topic shows the areas that companies consider most important as they enter 2011,” said Jason Richardson, president of Cutting Edge Information.

“These are the areas executives believe offer both challenges and opportunities that can provide competitive advantage if managed well in the next year.”

The lists below include both the subject areas identified by industry executives and the top project conducted by Cutting Edge Information (http://www.cuttingedgeinfo.com/) for that functional group.

Top 3 Medical Affairs Reports
#1 Thought Leader Fair-Market Value: Compensation Benchmarks and Procedures
#2 Medical Science Liaison Programs — The New MSL Profile: Internal Thought Leader, External Voice and Clinical Catalyst
#3 Pharmaceutical and Medical Device Regulatory Affairs

Top 3 Clinical Development Reports
#1 Benchmarking Drug Safety and Pharmacovigilance
#2 Streamlining Clinical Trials
#3 Clinical Trial Patient Recruitment

Top 3 Decision Support and Forecasting Reports
#1 Oncology Market Forecast to 2015
#2 Strategic Pharmaceutical Competitive Intelligence
#3 Diabetes Market Forecast to 2015

Top 3 Market Access Reports
#1 Health Economics and Outcomes Research
#2 Securing Market Access: Reimbursement, Payer Relationships and Healthcare Reform
#3 Outcomes-Based Pharmaceutical Pricing: Meeting Stakeholder Needs

Top 3 Portfolio Planning and Business Development Challenges
#1 Lifecycle Management: Strategy, Selection and Execution
#2 Pharmaceutical and Biotechnology Business Development: Accelerating the Deal
#3 Pharmaceutical Alliance Management

Top 3 Marketing and Commercialization Reports
#1 Countering Generics and Biosimilar Threats
#2 Pharmaceutical Speaker Programs
#3 Driving Successful Pharmaceutical Brands

Cutting Edge Information will continue to analyze key trends emerging from 2010 and impacting 2011 and beyond. More detail and background about Cutting Edge Information is available through the pharmaceutical Twitter feed, the life sciences research and consulting LinkedIn page, and a set of complimentary newsletters providing new management analysis monthly.

For media inquiries, please contact
Stephanie Swanson
919-403-6583
Email Contact

Click here to see all recent news from this company

Filed Under: Facilities And Providers

Surrex Announces Strategic Partnership With gloStream

Posted on December 9, 2010 Written by Annalyn Frame

SOURCE: Surrex EHR Solutions

EL SEGUNDO, CA–(Marketwire – December 9, 2010) –  Surrex EHR Solutions (www.surrex-ehr.com), a rapidly growing US based Healthcare IT Consulting firm, and gloStream (www.glostream.com), the world’s only provider of a Meaningful Use ready Electronic Health Records system (EHR) with MS Office built directly in, today announced the formation of a strategic partnership through which Surrex will perform sales, implementation and system integration of the gloStream platform for physician offices around the United States. 

Recognizing the need for a powerful, effective, and highly efficient EHR and Practice Management solution in small and medium sized medical offices, Surrex selected gloStream for their easy-to-use MS Office based technology, state of the art integration with Voice Recognition software, and top tier customer support. gloSuite, an integrated EHR and PM platform, allows Physicians to dictate directly into a patient’s Electronic Medical Record, ePrescribe, and perform other critical day to day tasks. Medical office staff can rapidly customize templates and documents, file insurance claims, interface with 3rd billing services, and much more.

“Our team evaluated dozens of meaningful use certified EHR platforms as we sought to identify viable Partners,” said Tristan Carey, President of Surrex EHR Solutions. “gloStream was one of a very small number of organizations that met our criteria for product quality, process management, solutions integration, pricing, and ongoing customer support. We’re very pleased to be one of the newest members of the gloStream Partner community.”

“We are proud and excited to welcome Surrex to the gloStream community,” said Brenda Hodge, gloStream’s Executive Vice President for Partners and Practices. “Their level of commitment to the gloStream Partner Program ensures that physicians all over the U.S. will have access to not only the best EMR and PM software, but also to an IT advisor that can implement and support entire networks and essential data.”

Both companies anticipate a highly successful partnership and look forward to serving the physician marketplace across the United States. 

Surrex EHR Solutions specializes in the selection, implementation, integration, and support of Electronic Medical Records (EMR / EHR) and Practice Management (PM) solutions. Contact Surrex at www.surrex-ehr.com, or by calling 1-877-4SURREX (877-478-7739).

gloStream provides doctors with certified, voice-enabled electronic medical record and practice management solutions delivered and supported through a nationwide community of local technology Partners. gloStream products are secure, easy-to-use applications and the only solutions on the market with Microsoft Office built right in. 

Contact:
Michael Junge
949-202-5839

Filed Under: Facilities And Providers

St. Clair Hospital Replaces Scheduling System With Versus RTLS

Posted on December 7, 2010 Written by Annalyn Frame

SOURCE: Versus Technology, Inc.

TRAVERSE CITY, MI–(Marketwire – December 7, 2010) – St. Clair Hospital Outpatient Surgery Center in Pittsburgh, PA has selected the Versus Advantages Real-time Locating System (RTLS) from Versus Technology, Inc. (Versus) (PINKSHEETS: VSTI) to improve nurse-to-patient assignment and continue automated nurse call cancellation functionality throughout the 34,000 sq. ft. same-day surgical center. The center anticipates an increase in patient volume and looked to RTLS automation to enhance workflow processes.

Versus has provided location information, call cancellation and patient flow to St. Clair for many years. This was primarily to automate a separate system (part nurse call, part scheduling) provided by a nurse call vendor that no longer fully supports the product. The Outpatient Surgery Center genuinely relied on this system for displaying patient and nurse location, assigning nurses to patients and patient readiness. However, the system required manual data entry and is no longer supported.

Working with Intelligent Electronic Systems, Inc. (IES), the local Pittsburgh GE Telligence dealer, Versus designed a new solution for St. Clair which utilizes much of their existing RTLS network, retains well-liked features from their old system and automates several additional features to improve patient care and efficiency. The most notable of these features is Versus’ new Schedule View, which offers caregivers a consolidated view of scheduled appointments and other applicable data. It can be sorted by provider or date, allowing users to filter information relevant to their own responsibilities. This view is an extension of Versus’ Enterprise View, which provides real-time, Glance-and-Go™ clinical information on Floorplans, List Views, Wait Views, etc.

Versus automates nurse-to-patient assignments based on a nurse’s physical presence in the patient room. However, St. Clair’s process required assignment of nurses to patients the night before based on the patient’s acuity and the nurse’s expertise or skill level. The current day’s appointments and assignments are then displayed in a single view. St. Clair’s current system was not equipped to address their pre-staffing requirement, so Versus developed and delivered this capability. Versus receives an inbound HL7 message from St. Clair’s Account Manager Patient Financial Management system allowed current scheduling procedures to be maintained while extending necessary features for nurse pre-assignment and automated nurse notification upon patient arrival.

Additionally, St. Clair’s staff will transition from relying on nurse call lights to determine patient readiness to the web-based Versus Advantages solution. This allows all staff, including those in other departments like radiology or surgery, to determine patient readiness and room availability. Staff will continue to benefit from real-time locating of patients, staff and equipment, as well as wait time alerts and the traditional automated nurse registry and call cancellation that results from Versus’ integration to any nurse call system.

Versus is working closely with St. Clair’s HIS staff (contracted Allscripts employees) and IES to finalize the workflow process that will drive their Enterprise interfaces and communication configurations to pagers.

About St. Clair Hospital
St. Clair Hospital is an independent, acute care facility that provides advanced, high quality health care to more than 400,000 residents of southwestern Pennsylvania. With 525 physicians and more than 2,000 employees, St. Clair is the largest employer in Pittsburgh’s South Hills. Providing virtually every health care service that residents might need throughout their lives, the Hospital combines advanced technologies with exceptional medical expertise to ensure that the community’s health needs are met. For more information, please visit www.stclair.org.

About IES
IES is a life safety sales and service company. They provide Fire Alarm Systems, Nurse Call Systems, CCTV/Security Systems, Access Control Systems, and Fire Alarm Testing/Service Agreements. IES has been chosen by GE Healthcare above all others as their preferred healthcare communication systems company in Southwestern Pennsylvania.

About Versus Technology, Inc.
Established in 1988, Versus Technology, Inc. specializes in real-time location systems (RTLS) for healthcare. Used for enterprise patient tracking, bed management, asset tracking, and nurse call automation, Versus Advantages™ improves patient flow and documentation of caregiver and patient interactions, while enhancing communication and efficiency. Exclusively endorsed by the American Hospital Association, the Versus Advantages infrared (IR) and Active RFID solution is responsible for clinical-grade location and automation at a number of hospitals, clinics and long-term care facilities worldwide. To learn more about Versus Technology, Inc. (PINKSHEETS: VSTI), our technology and client successes, visit www.versustech.com and take the Advantages Tour.

Safe Harbor Provision
This release may include forward-looking statements which “bespeak caution,” and which are subject to risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. The statements are made only as of the date of this release, and the Company undertakes no obligation to update them to reflect subsequent events or circumstances.

Media Contact:
Versus Technology, Inc.
Stephanie Bertschy
Director of Marketing
877.983.7787
Email Contact

Investor/Analyst Contact:
Versus Technology, Inc.
Joseph Winowiecki
Chief Financial Officer
231.946.5868
Email Contact

Click here to see all recent news from this company

Filed Under: Facilities And Providers

StepStoneMed Announces Web-Based Virtual Patient Cases — Transforming Medical Education

Posted on December 7, 2010 Written by Annalyn Frame

SOURCE: StepStoneMed

Medical Educators Endorse the Virtual Patient Approach as a Highly Effective, Innovative Way to Bridge the Learning Gap Between Textbook and Patient Bedside

HOUSTON, TX–(Marketwire – December 7, 2010) – StepStoneMed™, the emerging leader in innovative solutions for medical education, today announced a new and innovative virtual patient module, Classic Cardiac Codes©. Designed to teach the latest advancements in Advanced Cardiac Life Support (ACLS), Classic Cardiac Codes is a series of web-based interactive lessons designed to teach clinical medicine to students and physicians. The module features ten virtual-patient encounters specifically created to advance learning and retention of some of the most urgent conditions faced by healthcare professionals, regardless of their area of specialization. Traditional resources in medical education and CME are text-based and often dry and boring. StepStoneMed lessons feature memorable, well-developed characters designed to personify the medical conditions they each represent. Learners are guided by the “StepStones,” a navigational progress bar and electronic flashcard system, designed to teach and reinforce the correct sequence of evidence-based medical management decisions. Each case ends with a review of the appropriate protocols, standards of care, and additional resources for the learner. Preliminary studies have demonstrated that medical students using StepStoneMed test at significantly higher levels of mastery and retain their knowledge longer than students depending on traditional methods alone.

Medicine is best learned at the bedside, where book-based facts about diseases, symptoms, and appropriate interventions are translated into patient-based knowledge. Unfortunately, exposure to patients with a variety of conditions is severely limited during traditional medical education. The result is insecure young doctors, inefficient patient care, and escalating costs for diagnostic testing. StepStoneMed has been designed specifically to address this limitation, using the proven educational psychology principles and the latest e-learning technologies.

“This novel approach to medical education incorporates the best of how students, residents and practicing physicians learn. It is interactive, accurate, and simulates the complex way that doctors learn to make decisions in emergency situations. This is a great way to learn how to navigate emergency situations, or to practice these scenarios from time to time to keep these critical skills up to date,” said Mary L. Brandt, MD, Professor and Vice Chair, Michael E. DeBakey Department of Surgery, Baylor College of Medicine.

According to one of StepStoneMed’s founders, David Eagleman, PhD, Department of Neuroscience, Baylor College of Medicine, “This is the future of learning. As neuroscience demonstrates, we learn best when we’re presented with active decision-making, emotional salience, and memorable narrative. These patients — and the lessons they teach — are impossible to forget.”

Caroline Popper, MD, MPH, President, BCM Technologies, Inc., said, “StepStoneMed combines great medical education with innovation in information technology. The confluence of Healthcare and Technology is a major market trend, and BCM Technologies is very excited to work with terrific Baylor entrepreneurs in this company.”

“StepStoneMed bridges the gap from books to bedside with our virtual patients, cleverly designed to personify disease in a memorable way. Our structured guidance through correct diagnosis and intervention protocols ensures effective learning for every medical specialty,” said Cynthia Sheridan, Chief Executive Officer, StepStoneMed. “This new module of cases has been proven to dramatically increase med students’ understanding and long term retention of information.”

StepStoneMed’s interactive learning module, Classic Cardiac Codes, is available today. The module is cost-effective and priced specifically for medical students. For a limited time, students can get two of the cases at no charge by using their medical school email address when they register at www.stepstonemed.com. StepStoneMed modules are also available for academic institutions on a departmental or campus-wide basis.

About StepStoneMed

StepStoneMed was created by a medical student at Baylor College of Medicine, under the mentorship of Professors of Surgery and Neuroscience. Their application is the only virtual patient case tool that offers structured, evidence-based learning in the form of case modules for all the medical specialties. StepStoneMed provides a memorable connection between patient and disease, is readily available to every student over the web, and contains the most current protocols and standards of care.

StepStoneMed is led by a team of seasoned professionals with a unique blend of experience in medicine, medical education, e-learning, software commercialization and serious game design. For more information, visit www.stepstonemed.com.

Media Contact:

Ruth Davidson
StepStoneMed, Inc.
713-795-0105
Email Contact

Click here to see all recent news from this company

Filed Under: Facilities And Providers

Santa’s on His Way… Santa Claus Isn’t Just Bringing Toys This Holiday Season, He’s Also Bringing Happiness to Kids and Families That Are Stricken…

Posted on December 7, 2010 Written by Annalyn Frame

SOURCE: Hair Fairies

LOS ANGELES, CA–(Marketwire – December 7, 2010) – Announced today, Santa Claus and some very special helpers will be visiting Hair Fairies salons (www.hairfairies.com) nationwide. Santa will be on site every Saturday in December through Christmas to deliver cheer, take photos, listen to wish lists and hand out special treats. The holiday season is upon us and nobody wants it ruined by having to deal with head lice. So, if these bugs happen to find their way into your home, what better way to get rid of them then at one of Hair Fairies unique salons, with the added benefit of meeting jolly ol’ St. Nick. The friendly technicians will work their magic with special techniques and 100% natural, non-toxic products. They will also be discounting many of their all natural Nit-Zapping™ head lice treatment products and up to 50% off your final treatment.

“The holiday season is an important time of year and we want families to be able to enjoy it the best way possible with fun, laughter, and free of lice!” stated Maria Botham, Founder and President of the Hair Fairies brand. “This is also a fun way to give back to the community.”

Hair Fairies, The Head Lice Helpers, the country’s leading head lice brand, has been helping millions of families that are stricken with head lice since 1999. To learn more about Hair Fairies salons and locations, their natural products and to order online, visit www.hairfairies.com. Even if you do not have head lice stop by and visit Santa and learn how you can prevent an outbreak in the future! 

HoHoHo… Happy Holidays from the Hair Fairies staff. 

For more information on the festivities you can
contact one of their salons at their toll free number,
Hair Fairies
1-877-285-0069

Click here to see all recent news from this company

Filed Under: Facilities And Providers

Allied Healthcare International Inc. Reports Fiscal 2010 Fourth Quarter and Year-End Results

Posted on December 7, 2010 Written by Annalyn Frame

SOURCE: Allied Healthcare International Inc.

Fiscal 2010 Revenues Increased 8.0%, at Constant Exchange Rates; Fiscal 2010 Operating Income Increased 7.7%, at Constant Exchange Rates & Excluding Acquisition Costs

NEW YORK, NY–(Marketwire – December 7, 2010) – Allied Healthcare International Inc. (NASDAQ: AHCI), a leading provider of flexible healthcare staffing services in the
United Kingdom, today issued financial results for its fiscal 2010 fourth
quarter and year-ended September 30, 2010.

To provide investors with a better understanding of the Company’s
performance and because of fluctuations in foreign exchange rates, Allied
is discussing its revenues, gross profit, selling, general & administrative
(SG&A) expenses and operating income at constant exchange rates, which are
calculated using the comparable prior period weighted average exchange
rates. In addition, as the Company’s revenues and gross profit from our
principal operations are denominated in pounds sterling but reported in
United States dollars, an analysis, which is contained in the Historical
Revenues and Gross Profit table at the end of this press release, is
included of the last eight quarters’ revenues and gross profit in pounds
sterling to enable investors to fully understand the underlying trends over
these periods without the effects of currency exchange rates.

Fiscal Fourth Quarter Results

              Three Months Ended
                 September 30,         Three Months Ended September 30,
            -----------------------  -------------------------------------
                                %                                     %
              2010     2009   Change   2010     %      2009     %   Change
            -------- -------- ------ -------  -----  -------- ----- ------
                    Revenues                     Gross Profit
            ------------------------ -------------------------------------

(Amounts in
 thousands)
Homecare    $64,244  $ 58,388  10.0% $19,934   31.0% $ 17,893  30.6%  11.4%
Nursing
 Homes        4,998     6,568 -23.9%   1,641   32.8%    2,070  31.5% -20.7%
Hospitals     5,120     4,889   4.7%   1,326   25.9%    1,233  25.2%   7.5%
            -------  -------- -----  -------         --------        -----
Total, at
 constant
 exchange
 rates       74,362    69,845   6.5%  22,901   30.8%   21,196  30.3%   8.0%
Effect of
 foreign
 exchange    (3,945)        -  -5.6%  (1,189)               -         -5.6%
            -------  -------- -----  -------         --------        -----
Total, as
 reported   $70,417  $ 69,845   0.8% $21,712         $ 21,196          2.4%
            =======  ======== =====  -------         --------        -----


                                                     SG&A
                                     -------------------------------------
SG&A, at
 constant
 exchange
 rates &
 excluding
 acquisition
 costs                               $19,033         $ 17,010         11.9%
Acquisition
 costs, at
 constant
 exchange
 rates                                   157                -          0.9%
                                     -------         --------        -----
SG&A, at
 constant
 exchange
 rates                                19,190           17,010         12.8%
Effect of
 foreign
 exchange                               (946)               -         -5.6%
                                     -------         --------        -----
Total SG&A,
 as reported                         $18,244         $ 17,010          7.3%
                                     -------         --------        -----


                                               Operating Income
                                     -------------------------------------
Operating
 income, at
 constant
 exchange
 rates &
 excluding
 acquisition
 cost                                $ 3,868         $  4,186         -7.6%
Acquisition
 costs, at
 constant
 exchange
 rates                                  (157)               -         -3.8%
                                     -------         --------        -----
Operating
 income, at
 constant
 exchange
 rates                                 3,711            4,186        -11.3%
Effect of
 foreign
 exchange                               (243)               -         -5.8%
                                     -------         --------        -----
Operating
 income, as
 reported                            $ 3,468         $  4,186        -17.2%
                                     =======         ========        =====


                                       Net Income Attributable to Allied
                                     -------------------------------------
                                              Basic           Basic
                                               and             and
                                             Diluted         Diluted
                                               EPS             EPS
                                     -------------------------------------
Income from continuing
 operations attributable
 to Allied, excluding
 acquisition costs                   $ 2,858  $0.07  $  2,937 $0.07
Acquisition Costs                       (146) -0.01         -     -
                                     -------  -----  -------- -----
Income from continuing
 operations attributable
 to Allied                           $ 2,712  $0.06  $  2,937 $0.07
                                     =======  =====  ======== =====

For the fourth quarter of fiscal 2010, total revenue increased 6.5%, to
$74.4 million, compared with $69.8 million reported during the same period
in fiscal 2009. Allied’s Homecare revenue grew 10.0% to $64.2 million. The
acquisition completed in our third fiscal quarter contributed 7.5%, or $4.4
million, to the increase in Homecare revenues. Nursing Homes revenue
declined 23.9% to $5.0 million and Hospitals revenue increased 4.7% to $5.1
million. After the unfavorable impact of currency exchange of $3.9 million,
revenue increased 0.8% year over year to the reported $70.4 million.

Total gross profit for the fourth fiscal quarter increased 8.0% to $22.9
million, from $21.2 million for the comparable quarter in fiscal 2009.
Homecare gross profit grew 11.4% to $19.9 million. The acquisition
completed in our third fiscal quarter contributed 7.6%, or $1.4 million, to
the increase in Homecare gross profit. Nursing Homes gross profit declined
20.7% to $1.7 million and Hospitals gross profit increased 7.5% to $1.3
million. Gross profit as a percentage of revenue was 30.8%, compared with
30.3% for the comparable prior-year period. Foreign exchange decreased
gross profit by $1.2 million to the reported $21.7 million for the 2010
fourth fiscal quarter.

SG&A, excluding acquisition costs, for the fourth fiscal quarter was $19.0
million (25.6% of revenues), an increase of 11.9%, from $17.0 million
(24.4% of revenues) reported last year. The acquisition completed in our
third fiscal quarter contributed 6.4%, or $1.0 million, to the increase in
SG&A. The Company also incurred acquisition costs of $0.1 million.
Foreign exchange decreased costs by $0.9 million to the reported $18.2
million for the 2010 fourth fiscal quarter.

Operating income, before acquisition costs, for the fourth quarter of
fiscal 2010 decreased by 7.6% to $3.9 million from $4.2 million a year ago.
Acquisition costs decreased operating income by $0.1 million. Foreign
exchange decreased operating income by $0.3 million to the reported $3.5
million for the 2010 fourth fiscal quarter.

Income from continuing operations attributable to Allied, excluding
acquisition costs, for the fourth quarter of fiscal 2010 was $2.9 million,
or $0.07 per diluted share. Income from continuing operations attributable
to Allied for the fourth quarter of fiscal 2010 was $2.7 million, or $0.06
per diluted share, compared with $2.9 million, $0.07 per diluted share,
reported during the 2009 fourth fiscal quarter.

Fiscal 2010 Full Year Results

            Year Ended September 30,       Year Ended September 30,
            ------------------------ -------------------------------------
                                %                                     %
              2010     2009   Change   2010     %      2009     %   Change
            -------- -------- ------ -------  -----  -------- ----- ------
                    Revenue                      Gross Profit
            ------------------------ -------------------------------------

(Amounts in
 thousands)
Homecare    $231,718 $203,885  13.7% $71,314   30.8% $ 63,176  31.0%  12.9%
Nursing
 Homes        18,469   25,863 -28.6%   5,971   32.3%    8,097  31.3% -26.3%
Hospitals     19,571   20,062  -2.4%   4,618   23.6%    5,075  25.3%  -9.0%
            -------- -------- -----  -------         --------       ------
Total, at
 constant
 exchange
 rates       269,758  249,810   8.0%  81,903   30.4%   76,348  30.6%   7.3%
Effect of
 foreign
 exchange      1,321        -   0.5%     402                -          0.5%
            -------- -------- -----  -------         --------       ------
Total, as
 reported   $271,079 $249,810   8.5% $82,305         $ 76,348          7.8%
            ======== ======== =====  -------         --------       ------


                                                    SG&A
                                     -------------------------------------
SG&A, at
 constant
 exchange
 rates &
 excluding
 acquisition
 costs                               $67,776         $ 63,234          7.2%
Acquisition
 costs, at
 constant
 exchange
 rates                                   752                -          1.2%
                                     -------         --------        -----
SG&A, at
 constant
 exchange
 rates                                68,528           63,234          8.4%
Effect of
 foreign
 exchange                                318                -          0.5%
                                     -------         --------        -----
Total SG&A,
 as reported                         $68,846         $ 63,234          8.9%
                                     -------         --------        -----


                                                 Operating Income
                                     -------------------------------------
Operating
 income, at
 constant
 exchange
 rates &
 excluding
 acquisition
 cost                                $14,127         $ 13,114          7.7%
Acquisition
 costs, at
 constant
 exchange
 rates                                  (752)               -         -5.7%
                                     -------         --------        -----
Operating
 income, at
 constant
 exchange
 rates                                13,375           13,114          2.0%
Effect of
 foreign
 exchange                                 84                -          0.6%
                                     -------         --------        -----
Operating
 income, as
 reported                            $13,459         $ 13,114          2.6%
                                     =======         ========        =====


                                       Net Income Attributable to Allied
                                     -------------------------------------
                                              Basic            Basic
                                               and              and
                                             Diluted          Diluted
                                               EPS              EPS
                                     -------------------------------------
Income from continuing
 operations attributable to
 Allied, excluding
 acquisition cost                    $10,624  $0.24  $  9,936 $0.22

Acquisition costs                       (756) -0.02         -     -
                                     -------  -----  -------- -----
Income from continuing
 operations attributable to
 Allied                              $ 9,868  $0.22  $  9,936 $0.22
                                     =======  =====  ======== =====

For the year ended September 30, 2010 total revenue increased 8.0%, to
$269.8 million, compared with $249.8 million for the same period in fiscal
2009. Allied’s Homecare revenue grew 13.7% to $231.7 million. The
acquisition completed in the third quarter of fiscal 2010 contributed 3.2%,
or $6.5 million, to the increase in Homecare revenues. Nursing Homes
revenue declined 28.6% to $18.5 million and Hospitals revenue declined 2.4%
to $19.6 million. After the favorable impact of currency exchange of $1.3
million, revenue increased 8.5% year over year to the reported $271.1
million for fiscal 2010.

Total gross profit for the year ended September 30, 2010 increased 7.3% to
$81.9 million, from $76.3 million for the comparable period in fiscal 2009.
Homecare gross profit grew 12.9% to $71.3 million. The acquisition
completed in our third fiscal quarter contributed 3.1%, or $2.0 million, to
the increase in Homecare gross profit. Nursing Homes gross profit declined
26.3% to $6.0 million and Hospitals gross profit declined 9.0% to $4.6
million. Gross profit as a percentage of revenue was 30.4%, compared with
30.6% for the comparable prior-year period. Foreign exchange increased
gross profit by $0.4 million to the reported $82.3 million for fiscal 2010.

SG&A, excluding acquisition costs, for the year ended September 30, 2010
was $67.8 million (25.1% of revenues), an increase of 7.2%, from $63.2
million (25.3% of revenues) reported last year. The acquisition completed
in our third fiscal quarter contributed 2.4%, or $1.5 million, to the
increase in SG&A. We also incurred acquisition costs of $0.7 million.
Foreign exchange increased costs by $0.3 million to the reported $68.8
million for fiscal 2010.

Operating income, before acquisition costs, for the year ended September
30, 2010 increased by 7.7% to $14.1 million from $13.1 million a year ago.
Acquisition costs decreased operating income by $0.7 million. Foreign
exchange increased operating income by $0.1 million to the reported $13.5
million for fiscal 2010.

Income from continuing operations attributable to Allied, excluding
acquisition costs, for the year ended September 30, 2010 was $10.6 million,
or $0.24 per diluted share. Income from continuing operations attributable
to Allied for the year ended September 30, 2010 was $9.9 million, or $0.22
per diluted share, compared with $9.9 million, $0.22 per diluted share,
reported during fiscal 2009.

At September 30, 2010 and September 30, 2009, Allied cash balance was $39.0
million (£24.7 million) and $35.3 million (£22.2 million), respectively,
represent an underlying increase in the cash balance of $3.7 million (£2.5
million).

For the year ended September 30, 2010, depreciation and amortization was
$4.4 million (£2.8 million), capital expenditures were $2.8 million (£1.8
million). Days Sales Outstanding was 26 days at September 30, 2010 (43 days
including unbilled account receivables), and 25 days at September 30, 2009
(40 days including unbilled account receivables).

Management Discussion

Sandy Young, Chief Executive Officer of Allied, commented, “Allied’s
financial performance during the fourth quarter reflects tightening in the
U.K. government’s spending and challenging macroeconomic factors. The
acquisition of Homecare business in Ireland contributed $4.4 million to
Allied’s top line during the quarter, resulting in 10% growth of our
Homecare revenue compared to the fourth quarter a year ago. Excluding the
acquisition, our Homecare revenue grew 2.5% year over year, with an 11.5%
increase in continuing care.

“In order to reduce the U.K. government’s fiscal deficit, following its
Comprehensive Spending Review, HM Treasury announced in October 2010 its
plans to achieve a significant reduction in public spending. While the U.K.
government has stated that it will increase spending in the National Health
Service over the next four years to support healthcare, we note the
increase will be partially offset as the NHS have increased obligations and
cost of treatments going forward due to the growing population and demand
for better healthcare. However, the Comprehensive Spending Review will
also allocate £2 billion a year of additional funding by 2014-15 to support
social care. Combined with a program of reform and efficiency savings,
such as greater use of personal budgets, the U.K. government believes this
should mean local authorities should be able to improve outcomes and should
not need to reduce eligibility for services.

“The Comprehensive Spending Review also announced significant cuts in
funding to local authorities, the main providers of social care, and other
public bodies, which are a key source of revenue to Allied. Individual
local authorities will decide which of their back office costs and front
line services to allocate savings to.

“Based on the current and anticipated changes in the U.K. government’s
policies, we believe that it is possible that demand will be flat on a
consecutive basis for the near term. However, due to Allied’s favorable
position in the industry, strong reputation and innovative business
approach, we expect to return to growth in the mid-term.

“Allied is in a good position to benefit from joint commissioning of health
and social care. For example:

-- Within our homecare revenue, we have over $159 million (£102 million) in
   social care revenue, $57.7 million (£37 million) in continuing care
   revenue and $13.3 million (£8.5 million) in learning disability revenue;
-- We are introducing new Primary Care Trust services this year. They will
   include our night roaming service, our end of life services and other
   specialist health services;
-- We are winning extra care contracts, a potentially new revenue stream;
-- We are looking at new homecare solutions, including
   Telecare/Telehealth; and
-- We are extending the boundaries of the care and supported living we
   provide to include children's services and services for drug and alcohol
   abuse.  Some of these require rental housing to be part of the package.

“Although we anticipate that there will be continuing tension in spending,
we believe that councils and PCTs are likely to:

-- Outsource more than they do at present, particularly in Scotland, Wales
   and Ireland;
-- Have the ability to get incremental savings by directing greater volumes
   to providers of scale like Allied;
-- Keep individuals out of hospital and in their own homes;
-- Favor lower cost homecare over more  expensive residential care;
-- Pursue new and quite entrepreneurial services around the end of life
   pathway; and
-- Still need to provide for the increasing numbers of elderly each year.

“So today, Allied can claim to be one of the leading providers of health
and social care in the U.K., and we continue to expand our market
footprint. During the fourth quarter and in subsequent months we won a
number of domiciliary care framework contracts, the two largest being:

-- East Sussex County Council -- Up to 2,000 hours per week for four years,
   which commenced November 2010.
-- Cardiff City Council -- Up to 2,000 hours per week for three years,
   commencing April 2011.

“In addition we have won a community homecare contract with Leeds City
Council and NHS, and a contract for nursing supplied with Welsh Health
Supply. We have also seen a number of positive wins in continuing care from
framework agreements, including Doncaster and an additional opportunity in
Sheffield.

“In a consistent pursuit of improving and expanding our value proposition,
we continued to make investments in our operational infrastructure. To
date, 55 of our branches are live on Coldharbour, and the software rollout
is continuing according to plan. Our customer complaints and risk
management system, which was built in house, is currently under testing and
is planned to go live at the beginning of calendar 2011. Additionally, we
are actively working on several other projects, such as call monitoring,
carer retention and the centralization of our on-call out of hours service.
We also piloted our recruitment screening and compliance department project
in Wales and have received very positive feedback. Our recruitment pipeline
tracker is undergoing design changes for full rollout to the business in
the near future.

“In summary, Allied is well positioned to capitalize on the growing elderly
population, shift from residential to homecare services and the move
towards joint commissioning of health and social care,” concluded Mr.
Young.

Dr. Jeffrey Peris, Chairman of Allied, commented, “The Board remains
confident in the opportunities for growth through management actions on
innovative initiatives. Based on our identified strategies for growth
being successfully implemented, our financial track record over the last
few years, our focus and results in improving operating efficiencies, and
the recruitment and retention of talented people — we continue to strive
to enhance shareholder value.”

Conference Call Information: December 7, 2010 at 10:00 AM Eastern Time /
3:00 PM UK Time

Allied will host a call and webcast today at 10:00 AM Eastern Time / 3:00
PM UK Time, to discuss its financial results. To join the call, please dial
(877) 407-8031 for domestic participants and (201) 689-8031 for
international participants. Participants may also access a live webcast of
the conference call through the “Investors” section of Allied Healthcare’s
Website: www.alliedhealthcare.com. A telephone replay will be available for
two weeks following the call by dialing (877) 660-6853 for domestic
participants and (201) 612-7415 for international participants. When
prompted, please enter account number 286 and conference ID number 360782.
A webcast replay will also be available and archived on the Company’s
website for ninety days.

Reconciliation of GAAP and Non-GAAP Data

In addition to disclosing results of operations that are determined in
accordance with generally accepted accounting principles (“GAAP”), this
press release also discloses non-GAAP results of operations that exclude or
include certain charges. These non-GAAP measures adjust for foreign
exchange effects and acquisition costs. Management believes that the
presentation of these non-GAAP measures provides useful information to
investors regarding the Company’s results of operations, as these non-GAAP
measures allow investors to better evaluate ongoing business performance.
Investors should consider non-GAAP measures in addition to, and not as a
substitute for, financial measures prepared in accordance with GAAP. A
reconciliation of the non-GAAP measures disclosed in this press release
with the most comparable GAAP measures are included in the financial tables
included in this press release.

ABOUT ALLIED HEALTHCARE INTERNATIONAL INC.

Allied Healthcare International Inc. is a leading provider of flexible
healthcare staffing services in the United Kingdom. Allied operates a
community-based network of approximately 115 branches with the capacity to
provide carers (known as home health aides in the U.S.), nurses, and
specialized medical personnel to locations covering approximately 90% of
the U.K. population. Allied meets the needs of private patients, community
care, nursing and care homes, and hospitals. For more news and information
please visit: www.alliedhealthcare.com.

FORWARD-LOOKING STATEMENTS

Certain statements contained in this news release may be forward-looking
statements. These forward-looking statements are based on current
expectations and projections about future events. Actual results could
differ materially from those discussed in, or implied by, these
forward-looking statements. Factors that could cause actual results to
differ from those implied by the forward-looking statements include:
general economic and market conditions; the effect of the change in the
U.K. government and the impact of proposed changes in recent policy making
related to health and social care that may reduce revenue and
profitability; the impact of the HM Treasury Comprehensive Spending Review
2010 setting out the U.K. government’s plans to reduce spending; Allied’s
ability to continue to recruit and retain flexible healthcare staff;
Allied’s ability to enter into contracts with local government social
services departments, NHS Trusts, hospitals, other healthcare facility
clients and private clients on terms attractive to Allied; the general
level of demand and spending for healthcare and social care; dependence on
the proper functioning of Allied’s information systems; the effect of
existing or future government regulation of the healthcare and social care
industry, and Allied’s ability to comply with these regulations; the impact
of medical malpractice and other claims asserted against Allied; the effect
of regulatory change that may apply to Allied and that may increase costs
and reduce revenues and profitability; the effect of existing or future
government regulation in relation to employment and agency workers’ rights
and benefits, including changes to National Insurance rates and pension
provision; Allied’s ability to use net operating loss carry forwards to
offset net income; the effect that fluctuations in foreign currency
exchange rates may have on our dollar-denominated results of operations;
and the impairment of goodwill, of which Allied has a substantial amount on
the balance sheet, may have the effect of decreasing earnings or increasing
losses. Other factors that could cause actual results to differ from those
implied by the
forward-looking statements in this press release include those described in
Allied’s most recently filed SEC documents, such as its most recent annual
report on Form 10-K, all quarterly reports on Form 10-Q and any current
reports on Form 8-K filed since the date of the last Form 10-K. Allied
undertakes no obligation to publicly update or revise any forward-looking
statements, whether as a result of new information, future events, or
otherwise.

ALLIED HEALTHCARE INTERNATIONAL INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)


                                         Year Ended  Year Ended  Year Ended
                                         September   September   September
                                          30, 2010    30, 2009    30, 2008
                                         ----------  ----------  ---------
Revenues:
    Net patient services                 $  271,079  $  249,810  $ 298,577
                                         ----------  ----------  ---------

Cost of revenues:
    Patient services                        188,774     173,462    208,192
                                         ----------  ----------  ---------

          Gross profit                       82,305      76,348     90,385

Selling, general and administrative
 expenses                                    68,846      63,234     77,655
                                         ----------  ----------  ---------

          Operating income                   13,459      13,114     12,730

Interest income                                 361         537        935
Interest expense                                (30)       (110)      (542)
Foreign exchange loss                          (210)       (197)      (586)
                                         ----------  ----------  ---------

          Income before income taxes
           and discontinued operations       13,580      13,344     12,537

Provision for income taxes                    3,524       3,408      3,751
                                         ----------  ----------  ---------

          Income from continuing
           operations                        10,056       9,936      8,786
                                         ----------  ----------  ---------

Discontinued operations:
Income from discontinued operations,
 net of taxes                                     -         367          -
                                         ----------  ----------  ---------

Net income                                   10,056      10,303      8,786

Less:  Net income attributable to
 noncontrolling interest                       (188)          -          -
                                         ----------  ----------  ---------

Net income attributable to Allied
 Healthcare International Inc.           $    9,868  $   10,303  $   8,786
                                         ==========  ==========  =========

Amounts attributable to Allied
 Healthcare International Inc.:
          Income from continuing
           operations, net of tax        $    9,868  $    9,936  $   8,786
          Discontinued operations,
           net of tax                             -         367          -
                                         ----------  ----------  ---------
          Net income                     $    9,868  $   10,303  $   8,786
                                         ==========  ==========  =========

Basic earnings per share - attributable
 to Allied Healthcare International Inc.
 common shareholders
          Income from continuing
           operations                    $     0.22  $     0.22  $    0.20
          Income from discontinued
           operations                             -        0.01          -
                                         ----------  ----------  ---------
Net income attributable to Allied
 Healthcare International Inc. common
 shareholders                            $     0.22  $     0.23  $    0.20
                                         ==========  ==========  =========

Diluted earnings per share - attributable
 to Allied Healthcare International Inc.
 common shareholders
          Income from continuing
           operations                    $     0.22  $     0.22  $    0.19
          Income from discontinued
           operations                             -        0.01          -
                                         ----------  ----------  ---------
Net income attributable to Allied
 Healthcare International Inc. common
 shareholders                            $     0.22  $     0.23  $    0.19
                                         ==========  ==========  =========

Weighted average number of common
 shares outstanding:
          Basic                              44,796      44,986     44,986
                                         ==========  ==========  =========
          Diluted                            45,009      45,011     45,078
                                         ==========  ==========  =========





ALLIED HEALTHCARE INTERNATIONAL INC.
CONSOLIDATED BALANCE SHEETS
(In thousands, except per share data)

                                              September 30,  September 30,
                                                  2010           2009
                                              -------------  -------------
                          ASSETS

Current assets:
  Cash and cash equivalents                   $      39,031  $      35,273
  Accounts receivable, less allowance for
   doubtful accounts of $732 and $839,
   respectively                                      20,092         19,594
  Unbilled accounts receivable                       13,393         11,572
  Deferred income taxes                                 552            389
  Prepaid expenses and other assets                   1,943          1,188
                                              -------------  -------------
         Total current assets                        75,011         68,016

Property and equipment, net                           8,924          7,756
Goodwill                                            102,945         95,649
Other intangible assets, net                          3,501          1,646
                                              -------------  -------------
         Total assets                         $     190,381  $     173,067
                                              =============  =============

       LIABILITIES AND SHAREHOLDERS' EQUITY

Current liabilities:
  Accounts payable                            $       1,581  $       1,186
  Current maturities of debt and capital leases         614              -
  Accrued expenses, inclusive of payroll and
   related expenses                                  25,897         24,304
  Taxes payable                                       2,310            201
                                              -------------  -------------
         Total current liabilities                   30,402         25,691

Long-term debt and capital leases, net of
 current maturities                                     389              -
Deferred income taxes                                 1,534            103
Other long-term liabilities                             308              -
                                              -------------  -------------
         Total liabilities                           32,633         25,794
                                              -------------  -------------

Commitments and contingencies

Noncontrolling interest                               4,358              -
                                              -------------  -------------

Shareholders' equity:
  Preferred stock, $.01 par value; authorized
   10,000 shares, issued and outstanding - none           -              -
  Common stock, $.01 par value; authorized
   80,000 shares, issued 45,721 and 45,571
   shares, respectively                                 457            456
  Additional paid-in capital                        242,478        241,555
  Accumulated other comprehensive loss              (15,267)       (14,418)
  Accumulated deficit                               (68,158)       (78,026)
                                              -------------  -------------
                                                    159,510        149,567
  Less cost of treasury stock (2,150 and 585
   shares, respectively)                             (6,120)        (2,294)
                                              -------------  -------------
         Total shareholders' equity                 153,390        147,273
                                              -------------  -------------
         Total liabilities and shareholders'
          equity                              $     190,381  $     173,067
                                              =============  =============





ALLIED HEALTHCARE INTERNATIONAL INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)

                                        Year Ended  Year Ended  Year Ended
                                        September   September   September
                                         30, 2010    30, 2009    30, 2008
                                        ----------  ----------  ----------
Cash flows from operating activities:
  Net income                            $   10,056  $   10,303  $    8,786
  Adjustments to reconcile net income
   to net cash provided by operating
   activities:
    Income from discontinued operations          -        (367)          -
    Depreciation and amortization            3,108       2,590       3,231
    Amortization of intangible assets        1,324       1,252       1,634
    Foreign exchange (gain) loss               (43)          7           -
    Increase (decrease) in provision for
     allowance for doubtful accounts            30         360        (167)
    Loss on sale of fixed assets                31          20         166
    Stock based compensation                   636         537         812
    Deferred income taxes                       61         117          88
  Changes in operating assets and
   liabilities, excluding
   the effect of businesses acquired
   and sold:
    Decrease (increase) in accounts
     receivable                                 82      (4,281)      1,579
    (Increase) decrease in prepaid
     expenses and other assets              (1,544)      2,318      (3,488)
    Increase (decrease) in accounts
     payable and other liabilities           2,260       2,867      (3,779)
                                        ----------  ----------  ----------

      Net cash provided by continuing
       operations                           16,001      15,723       8,862
      Net cash used in discontinued
       operations                                -           -        (561)
                                        ----------  ----------  ----------
      Net cash provided by operating
       activities                           16,001      15,723       8,301
                                        ----------  ----------  ----------

Cash flows from investing activities:
  Capital expenditures                      (2,768)     (2,850)     (3,344)
  Acquisition of controlling interest,
   net of cash acquired                     (5,680)          -           -
  Proceeds from sale of business held in
   escrow and designated for debt
   repayment                                     -         116      53,638
  Proceeds from sale of property and
   equipment                                    73           1          50
  Payments on acquisitions payable               -      (1,082)          -
                                        ----------  ----------  ----------

      Net cash (used in) provided by
       investing activities                 (8,375)     (3,815)     50,344
                                        ----------  ----------  ----------

Cash flows from financing activities:
  Repayments of debt and capital lease
   obligations                                (152)          -           -
  Payments under revolving loan, net             -           -     (24,664)
  Borrowings (payments) under invoice
   discounting facility, net                   255           -      (4,458)
  Principal payments on long-term debt           -           -     (23,678)
  Proceeds from sale of interest rate
   swap agreements                               -           -         617
  Treasury shares acquired                  (3,826)          -           -
  Stock options exercised                      288           -           -
                                        ----------  ----------  ----------

      Net cash used in financing
       activities                           (3,435)          -     (52,183)
                                        ----------  ----------  ----------

Effect of exchange rate on cash               (433)     (2,834)       (504)
                                        ----------  ----------  ----------

Increase in cash                             3,758       9,074       5,958

Cash and cash equivalents, beginning of
 year                                       35,273      26,199      20,241
                                        ----------  ----------  ----------

Cash and cash equivalents, end of year  $   39,031  $   35,273  $   26,199
                                        ==========  ==========  ==========

Supplemental cash flow information:
  Cash paid for interest                $       30  $      405  $    1,143
                                        ==========  ==========  ==========

  Cash paid for income taxes, net       $    1,459  $    1,102  $    4,872
                                        ==========  ==========  ==========

Supplemental disclosure of non-cash
 investing and financing activities:
  Capital expenditures included in
   accrued expenses and other long-term
   liabilities                          $      609
                                        ==========

  Details of business acquired in
   purchase transactions:
    Fair value of assets acquired       $   12,319
                                        ==========

    Liabilities assumed or incurred     $    2,715
                                        ==========

    Noncontrolling interest             $    3,888
                                        ==========

    Cash paid for acquisitions          $    5,716
    Cash acquired                               36
                                        ----------

    Net cash paid for acquisitions      $    5,680
                                        ==========





ALLIED HEALTHCARE INTERNATIONAL INC.
HISTORICAL REVENUES AND GROSS PROFIT
(In thousands, except foreign exchange rate)
(Unaudited)


                                             Revenues

                             Q4           Q3           Q2           Q1
                            2010         2010         2010         2010
                        ------------ ------------ ------------ ------------

Homecare                  GBP 39,255   GBP 38,323   GBP 35,860   GBP 35,903
Nursing Homes                  3,048        2,731        2,864        3,261
Hospitals                      3,114        2,933        3,235        3,330
                        ------------ ------------ ------------ ------------
Total                     GBP 45,417   GBP 43,987   GBP 41,959   GBP 42,494
Foreign Exchange rate           1.55         1.49         1.56         1.63
                        ------------ ------------ ------------ ------------
                        $     70,417 $     65,748 $     65,530 $     69,384
                        ============ ============ ============ ============


                                           Gross Profit

                              Q4           Q3           Q2           Q1
                             2010         2010         2010         2010
                        ------------ ------------ ------------ ------------

Homecare                  GBP 12,188   GBP 11,651   GBP 11,083   GBP 11,041
Nursing Homes                  1,002          882          931        1,033
Hospitals                        812          696          755          712
                        ------------ ------------ ------------ ------------
Total                     GBP 14,002   GBP 13,229   GBP 12,769   GBP 12,786
Foreign Exchange rate           1.55         1.49         1.56         1.63
                        ------------ ------------ ------------ ------------
                        $     21,712 $     19,768 $     19,948 $     20,877
                        ============ ============ ============ ============


                                             Revenues

                             Q4           Q3           Q2           Q1
                            2009         2009         2009         2009
                        ------------ ------------ ------------ ------------

Homecare                  GBP 35,763   GBP 34,162   GBP 30,858   GBP 30,620
Nursing Homes                  3,986        3,716        4,159        4,808
Hospitals                      2,956        2,914        3,448        3,612
                        ------------ ------------ ------------ ------------
Total                     GBP 42,705   GBP 40,792   GBP 38,465   GBP 39,040
Foreign Exchange rate           1.64         1.55         1.44         1.58
                        ------------ ------------ ------------ ------------
                        $     69,845 $     63,103 $     55,334 $     61,528
                        ============ ============ ============ ============


                                           Gross Profit

                             Q4           Q3           Q2           Q1
                            2009         2009         2009         2009
                        ------------ ------------ ------------ ------------

Homecare                  GBP 10,951   GBP 10,525    GBP 9,753    GBP 9,487
Nursing Homes                  1,257        1,187        1,298        1,477
Hospitals                        745          679          874          973
                        ------------ ------------ ------------ ------------
Total                     GBP 12,953   GBP 12,391   GBP 11,925   GBP 11,937
Foreign Exchange rate           1.64         1.55         1.44         1.58
                        ------------ ------------ ------------ ------------
                        $     21,196 $     19,173 $     17,166 $     18,813
                        ============ ============ ============ ============

Allied Healthcare International Inc.
Sandy Young
Chief Executive Officer
Paul Weston
Chief Financial Officer
+44 (0) 17 8581 0600

Or

ICR, LLC
Sherry Bertner
Managing Director
+1 646 277 1200
[email protected]

Filed Under: Facilities And Providers

The Global Awards Announces 2010 Winners; Grand Global Awards Go to Taxi Canada & McCann Healthcare Worldwide Japan

Posted on December 7, 2010 Written by Annalyn Frame

SOURCE: New York Festivals

The Global Awards Hosts Award Presentations in New York City and Sydney, Australia

NEW YORK, NY–(Marketwire – December 7, 2010) –   The Global Awards®, honoring the “World’s Best Healthcare Advertising™,” announced its 2010 award winners Monday, December 6th at a cocktail party held at the Eli Klein Gallery in New York. The competition will host two award presentations this year, taking the celebrations globally to New York, USA and Sydney, Australia. This year’s GrandJury® awarded two prestigious Grand Global Awards, one to Taxi Canada, and the second to McCann Healthcare Worldwide Japan, as well as 31 Global Awards and 115 Finalist Certificates. 

The Global Awards presentation in New York began with a cocktail reception and hors d’oeuvres; attendees viewed a print and video showcase of the “World’s Best Healthcare Advertising™.” Global Awards Executive Director Michael Demetriades and Global Awards Advisory Board Chairman & Draft FCB Healthcare Chairman Emeritus Tom Domanico presented the trophies to the 2010 award winners. Mr. Domanico commented on this year’s entries, “Each year I’m more impressed with the quality of the work submitted for judging. It speaks volumes about the talent in the Healthcare industry.”

The GrandJury awarded Taxi, of Toronto Canada, the prestigious Grand Global Award for “Antiquing/Strolling/Reading” for client Viagra, winning in Television Advertisement “Communication to the Consumer/Patient.” The premise of the award-winning commercials — when couples stop having sex, they fill the void with other couple activities that can end up taking over their lives; with the help of Viagra, these couples were able to get back into the bedroom again. 

Taxi’s Chief Creative Officer Steve Mykolyn accepted the award in New York and commented, “It’s great to win a Grand Global Award. This win is doubly great for TAXI and Pfizer because the work being recognized for Viagra had two things going for it; a fantastic insight, plus the power to entertain, even with repeated viewings. Make that three things. The campaign also had a positive impact on sales.”

Creative credits for “Antiquing/Strolling/Reading” include: Darren Clarke, Executive Creative Director; Nathan Montieth, Art Director/Writer; Stefan Wegner, Writer/Art Director; and Eugene Marchio, Agency Producer. In addition to the Grand Global Award, Taxi also received a Global Award for “Antiquing” for client Viagra.

McCann Healthcare Worldwide Japan was awarded the coveted Grand Global Award for “It’s Easy” for client Saizen (easy pod) Merck Serono, winning in New Product Launch “Communication to the Healthcare Professional.” The award-winning video illustrates a simple delivery device to administer human growth hormone and features a young girl dancing as she evolves into a woman. Creative credits include: Hajime Nakazawa, Creative Director & Copywriter; Yasutoshi Yamamoto, (Aoyama Creative Studio) Agency Producer; as well as Dee Drive’s Director Wataru Takeishi and Producer Yuko Niwa.

The United States was awarded 10 Global Awards: American Academy of Orthopaedic Surgeons for “Wounded in Action: An Art Exhibition of Orthopaedic Advancements”; Blue Shield of California for “Shield Helps”; CAHG for “Takeda Unbranded Convention Booth” for client Takeda Pharmaceuticals; Crowley Webb and Associates for “Risk Files Poster Campaign” for client Praxis; DeSantis Breindel for “Improving the Health and Health Care of All Americans: A Film About the Robert Wood Johnson Foundation” for client The Robert Wood Johnson Foundation; GSW Worldwide for “When the Body Attacks Itself Campaign” and “When the Body Attacks Itself Photography” for client Kalbitor; PALIO and ZEMOGA for “The Health Tweeder” for client The Health Tweeder. And Seiden was awarded two Global Awards, one for “The Book of Brave” for client Shire Pharmaceuticals, and a second for “Working Harder” for client Visiting Nurse Service of New York.

The 2010 Global Awards GrandJury recognized winners from 17 countries around the world. The United Kingdom received 5 Global Awards: Langland took the lead and was awarded 4 Global Awards receiving trophies for “Kogenate Self Infusion Mailer” for client Kogenate; “Real Danger” for client Pfizer; “Stalevo Dose Tool” for client Stalevo; and “Let’s Work” for Boehringer Ingelheim Oncology. In addition, Random42 Medical Animation was awarded the Global Award for “A Biotechnology Pioneer” for client Amgen Oncology; and RTC Europe was honored for “Siemens Global POS System” for Siemens Audiologische Technik GmbH.

In addition to Taxi Canada receiving both the Grand Global Award and Global Award for client Viagra, LXB Canada was also awarded a Global Award for “Sydney” for client Synagis.

Belgium, Germany, India, Italy, Spain, Sweden, and Switzerland each were honored with one Global Award. Norvell Jefferson Productions Belgium was honored with the Global Award for “The Making of Protein Therapies” for client Genzyme; Young & Rubicam GmbH Germany was awarded the Global Award for “Stairs” for BFF (Counseling for sexually abused or threatened women); McCann Healthcare Mumbai, India was awarded the Global Award for “Marriage/Study/Drive/Fly/Pleasure/Mother” for client Epilex Chromo; Sudler & Hennessey Italy garnered a Global Award for “From Science to Life” for client MIO, i.e. Milano International Oncology; HC BCN Spain was honored with a Global Award for “Bubbles” for client Aerored; Animech Sweden was acknowledged for “The Unknown Mr. Parkinson” for client EPDA; and Euro RSCG Zürich, Switzerland was recognized for “Quick Sex” for Swiss Health Department.

A Global Awards ceremony will also be held on Wednesday, December 8th in Sydney, Australia presented by The Global Awards and Bravo!, a group of Australian healthcare professionals, with representation from healthcare agencies, and the Communications Council of Australia. The evening will begin with a cocktail reception and canapés at Sydney’s Simmer on the Bay, located on historic Walsh Bay. Award winners and their guests will view a showcase of 2010’s winning work, followed by an award ceremony presented by International Awards Group President, Michael O’Rourke. Award Winners will be posted at www.theglobalawards.com following the event.

Judging sessions for this year’s Global Awards were hosted by the following prominent international agencies: McCann Erickson Sydney, Australia; Ogilvy Healthworld London, England; Pharmacom Barcelona, Spain; Topin & Associates Chicago, USA; Trademark DM Melbourne, Australia; and at The Global Awards headquarters in New York, USA. 

Now in its 16th year, The Global Awards receives entries from healthcare corporations, hospitals, advertising agencies, production companies, and design studios that produce communications for medical, pharmaceutical, and healthcare related products. The Global Awards Advisory Board and GrandJury are comprised of a panel of prominent international industry experts, representing the top creative minds in the field of healthcare advertising. 

All winning entries are featured at: www.theglobalawards.com, and are promoted by our network of representatives in 75 countries around the world.

All press inquiries are welcome and should be directed to Gayle Mandel: [email protected]. Phone 212 643 4800.

About the Global Awards
Now in their sixteenth year, The Global Awards are recognized as the only awards dedicated to excellence in healthcare communications on an international basis. 

International Awards Group International Awards Group (IAG) organizes advertising and programming competitions for the following brands: AME Awards® for the World’s Most Effective Advertising™; Midas Awards® for the World’s Best Work in Financial Marketing & Advertising™; The Global Awards® for the World’s Best Healthcare Advertising™; New York Festivals®; World’s Best Advertising™; World’s Best Radio Programs™ and World’s Best Television & Films™. Entries to each of the competitions are judged around the world by panels of peers in their respective industries. Founded in 1957, IAG and their brands now have representation in 75 countries. For more information, go to www.InternationalAwardsGroup.com.

Contact:
Gayle Mandel
International Awards Group
260 West 39
th Street, 10th Floor
New York, NY 10018
212 643-4800
[email protected]

Click here to see all recent news from this company

Filed Under: Facilities And Providers

CONMED Corporation Awarded Multiple Contracts With HealthTrust Purchasing Group

Posted on December 7, 2010 Written by Annalyn Frame

SOURCE: CONMED Corporation

UTICA, NY–(Marketwire – December 7, 2010) – CONMED Corporation (NASDAQ: CNMD) announced today that HealthTrust Purchasing Group, LP (HealthTrust), a leading healthcare group purchasing organization, recently awarded three separate, multi-year purchasing agreements with two of CONMED’s business units, Linvatec and Endoscopic Technologies.

CONMED Linvatec’s agreement enables HealthTrust members to purchase CONMED’s advanced endoscopic imaging products featuring state-of-the-art True HD™ technology. Products included in this agreement include the IM4000 autoclavable camera and image capture systems. 

CONMED reached a separate agreement with HealthTrust for its high-quality line of Enteral Feeding systems that feature the Entake™ family of products. In addition, the parties extended an existing agreement for CONMED Endoscopic Technologies’ extensive line of Gastroenterology (GI) products. Key products covered in this agreement include the Beamer™ System CE600, which is a GI specific electrosurgical/argon plasma generator with related accessories, as well as advanced biliary products such as the Gore Viabil® and Flexxus® metal stents.

“HealthTrust is nationally recognized for its membership’s strong commitment to purchasing products that consistently deliver enhanced clinical outcomes,” said Mr. Joseph J. Corasanti, President and CEO of CONMED. “We are extremely pleased that this large, high-quality group purchasing organization has recognized the unique advantages of our imaging, feeding and GI product offerings.”

ABOUT HEALTHTRUST PURCHASING GROUP

HealthTrust Purchasing Group, LP, headquartered in Brentwood, Tenn., is a group purchasing organization that supports nearly 1,400 not-for-profit and for-profit acute care facilities, as well as 10,600 ambulatory surgery centers, physician practices, and alternate care sites. With an annual purchasing volume by its members of more than $17 billion, HealthTrust is committed to obtaining the best price for clinically recommended products, ensuring their timely delivery, and continuously evaluating and improving its services to the patients, physicians and clinicians it serves. The website is www.healthtrustpg.com.

ABOUT CONMED CORPORATION

CONMED is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures and monitoring. The Company’s products serve the clinical areas of arthroscopy, gastroenterology, powered surgical instruments, electrosurgery, cardiac monitoring disposables, endosurgery and pulmonology. They are used by surgeons and physicians in a variety of specialties including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. Headquartered in Utica, New York, the Company’s 3,300 employees distribute its products worldwide from several manufacturing locations. The website is www.conmed.com.

Forward Looking Information

This press release contains forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The forward-looking statements in this press release involve risks and uncertainties which could cause actual results, performance or trends, to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management’s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct. In addition to general industry and economic conditions, factors that could cause actual results to differ materially from those discussed in the forward-looking statements in this press release include, but are not limited to: (i) the failure of any one or more of the assumptions stated above, to prove to be correct; (ii) the risks relating to forward-looking statements discussed in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009; (iii) cyclical purchasing patterns from customers, end-users and dealers; (iv) timely release of new products, and acceptance of such new products by the market; (v) the introduction of new products by competitors and other competitive responses; (vi) the possibility that any new acquisition or other transaction may require the Company to reconsider its financial assumptions and goals/targets; and/or (vii) the Company’s ability to devise and execute strategies to respond to market conditions

CONTACT:
CONMED Corporation
Robert Shallish
Chief Financial Officer
315-624-3206

FD
Investors:
Brian Ritchie
212-850-5600

Filed Under: Facilities And Providers

MYA Moves Into its AMAZING New Clinic in Bristol!

Posted on December 7, 2010 Written by Annalyn Frame

LEEDS, UNITED KINGDOM–(Marketwire – Dec. 7, 2010) – Cosmetic surgery is booming all over the UK, especially in the thriving West Country. MYA have seen a good level of new enquiries for the Bristol region over the last couple of years and with over five thousand enquiries since the launch of the company, MYA have decided to open a flagship clinic in the area.

John Ryan, Chairman of MYA and key industry figurehead, comments, “We’re really happy to move into our own building. This will really allow us to deliver the quality of care we’re famous for and put the ‘MYA touch’ on the new clinic.”

Amy Lansdown, manager of MYA Bristol said, “We’re really excited to have our new clinic. We’ve settled in nicely and since it’s just off Whiteladies Road, it’s a place that everyone knows about!”

Breast enlargement continues to be the most popular procedure enquired about in Bristol with other procedures following closely behind.

The top five procedure enquiries for Bristol are:

  • Breast Enlargement
  • Fat Removal/Liposuction
  • Nose Re-shaping
  • Tummy Tuck
  • Breast Uplift

With MYA’s successful Advanced Laser Liposuction launch in late October, the company is continually expanding and the new Bristol clinic is a great example of this. The new clinic is in a traditional Victorian-style building, boasting four floors, nine consulting rooms and a spacious reception area. “The new clinic and consulting rooms really allow for a cosy, personal feel when we’re meeting and chatting with our patients. The patients who have visited us in our new clinic absolutely love the traditional exterior and the modern, contemporary décor. It all adds to the truly amazing MYA experience” says Amy.

“We pride ourselves on providing a patient orientated service and we strive to offer the best care possible which includes having modern, comfortable clinics filled with helpful, friendly MYA staff” Says John. “We’re glad to be a part of this historic city’s culture and lifestyle and we hope you come and visit us soon.”

For more information about MYA Cosmetic Surgery visit the website www.mya.co.uk.

Notes to editors:

MYA Profile

MYA (Make Yourself Amazing) Cosmetic Surgery Ltd is a pioneering cosmetic surgery provider brought to you by John Ryan, the former owner of Transform Medical Group. John has over 25 years experience and has returned to cosmetic surgery enlisting the experience of the very best cosmetic surgeons and medical professionals in the industry. MYA pride themselves on their commitment to high quality service and medical supplies and have a comprehensive after-care policy. MYA’s world class expertise, competitive finance and state of the art national consultation centres are designed to ensure that Making Yourself Amazing is a reassuringly unique experience.

Filed Under: Facilities And Providers

Sunshine Heart Successfully Completes $9.5 Million Capital Raising With Close of Non-Renounceable Rights Offer

Posted on December 2, 2010 Written by Annalyn Frame

SOURCE: Sunshine Heart Inc.

Cash to Continue Rapid Advance of Commercial and Regulatory Programs

SYDNEY, AUSTRALIA–(Marketwire – December 2, 2010) –  Sunshine Heart Inc. (ASX: SHC), a global medical device company focused on innovative technologies for moderate to severe heart failure, today announced the successful completion of its non-renounceable rights issue to existing shareholders, raising a total of A$9.5 million.

88 per cent of entitlements were taken up under the rights issue including the shortfall facility, leaving 44,761,462 shares unsubscribed.

The rights issue follows the Company’s recent successful placement to US institutional investors raising A$3.7 million (announced 16 September 2010), bringing the total proceeds to A$13.2 million before deducting fees and expenses.

Majority Australian shareholders, GBS Venture Partners and CM Capital, both continued their strong support for the Company, taking up their full entitlements and also some of the shortfall, for an aggregate amount of $6.6 million

Sunshine Heart Chief Executive Officer Dave Rosa said, “We are delighted to have such strong support from existing shareholders and welcome new US institutional investors during this exciting and pivotal period for Sunshine Heart.”

The capital will be used to fund the key activities of the Company. The most important of these is to advance the regulatory trials in the US by completing the current 20-patient feasibility trial and six-month patient follow up, then preparing the application for the larger FDA pivotal trial which is the precursor for marketing approval in the USA. The Company expects to have approval for this trial and to start implants during 2011.

The money will also be used to apply for CE Mark approval in 2011 which will allow the C-Pulse heart assist device to be marketed in Europe and parts of Asia.

The Company will continue its development of a new, single unit C-Pulse driver as well as introducing product changes to facilitate minimally invasive implant procedures.

The successful US placement was managed by specialist healthcare investment firm Summer Street Research Partners Inc. The non-renounceable rights issue was managed by RBS Morgans in Australia.

About Sunshine Heart Inc.
Sunshine Heart Inc. (ASX: SHC), a global medical device company focused on innovative technologies for the treatment of moderate heart failure, is commercializing the C-Pulse® Heart Assist System, a minimally invasive, implantable, non-blood contacting, heart assist therapy for the treatment of moderate heart failure. The C-Pulse System is designed to relieve the symptoms of heart failure through the use of counterpulsation technology which enables an increase in cardiac output, an increase in coronary blood flow and a reduction in the heart’s pumping load. The Company has received approval from the US Food and Drug Administration (FDA) to conduct a 20-patient U.S. feasibility clinical trial with the C-Pulse System and the study has achieved eighty percent enrolment as of November 2010. Sunshine Heart, Inc. is a Delaware-based Corporation headquartered in Minneapolis with a subsidiary presence in Australia.

About the C-Pulse® Heart Assist System
The C-Pulse Heart Assist System uses proprietary balloon counterpulsation technology to increase the amount of blood pumped by the heart and to reduce the workload on the heart. The C-Pulse System is implanted in the patient’s chest through a sternotomy or through a small incision when performed as a minimally invasively procedure. During the procedure, there is no need to place the patient on a heart-lung machine as the patient’s heart remains beating continuously. 

Once implanted, the C-Pulse cuff is positioned on the outside of the patient’s ascending aorta above the aortic valve. An ECG sense lead is then attached to the heart to determine timing for cuff inflation and deflation in synchronization with the heartbeat. The C-Pulse cuff and lead are connected to a single line that is run through the abdomen to connect to a power driver outside the body. Because the C-Pulse System remains outside the blood system, there is potentially less risk of blood clots and stroke in comparison to other mechanical devices, such as left ventricle assist devices (LVADs).

This press release contains forward-looking statements that are based on current management expectations. These statements may differ materially from actual future events or results due to certain risks and uncertainties from time to time in the Company’s filings with the Australian Securities Exchange. The shares of Sunshine Heart have not been registered under the Securities Act of 1933 (US Securities Act) and may not be offered, sold or delivered in the United States, or to, or for the account or benefit of, any US Person, as such term is defined in Regulation S of the US Securities Act. In addition, hedging transactions with regard to the shares may not be conducted unless in accordance with the US Securities Act.

For further information, please contact:
Dave Rosa
Chief Executive Officer
+1 952 345 4200
[email protected]

Rowena Hubble
Company Secretary
+61 2 8424 7700
[email protected]

Andrew Geddes
CoActive Health Communications
+ 61 2 9555 4453 or 0408677734
[email protected]

Click here to see all recent news from this company

Filed Under: Facilities And Providers

HIMSS and ASC X12 Collaborate on Education & Training

Posted on December 2, 2010 Written by Annalyn Frame

SOURCE: ASC X12

CHICAGO, IL–(Marketwire – December 2, 2010) – Based on mutual interest in the use of effective and productive electronic data interchange standards in the health care industry, the Healthcare Information and Management Systems (HIMSS) and the Accredited Standards Committee X12 (ASC X12) signed a Memorandum of Understanding formalizing their decision to collaborate on activities and offerings that improve or enhance the implementation of EDI standards in the health care industry.

“ASC X12 and HIMSS have established a cooperative relationship, taking advantage of each organization’s strengths. We look forward to many productive joint initiatives,” said Cathy Sheppard, Chair, ASC X12.

The two organizations intend to collaborate in the development of educational materials, conference presentations, webinars, white papers, articles and reports.

Such cooperative efforts are not new between the organizations, HIMSS and ASC X12 have developed and presented a comprehensive overview of ASC X12 005010 migrations in the Webinar HIPAA 005010 Road to Success — A Prescription for a Healthy and Successful ASC X12 005010 Implementation. HIMSS also published the article ASC X12’s Emerging 5010 Activities, by Cathy Sheppard, in their August 2010 Business Edge online newsletter.

January 1, 2012 is the deadline for health care organizations to be compliant with the ASC X12 005010 transactions mandated by the Health Insurance Reform: Modifications to the Health Insurance Portability and Accountability Act (HIPAA) Electronic Transaction Standards Final Rule (also known as the 005010 Final Rule). ASC X12 and HIMSS are committed to aiding stakeholders in compliance preparation. 

ASC X12N (Insurance) Vice Chair, Bob Poiesz, will serve on an ASC X12 005010 migration panel at the HIMSS11 Annual Conference and Exhibition. The Ninth National Medical Banking Institute, to be held in conjunction with HIMSS11, features national experts and cross-industry leaders from health care, banking, financial systems, government and academia for an interactive dialogue of critical issues and next steps on building the future of medical banking. At the HIMSS Medical Banking Boot Camp ASC X12 will describe 005010 health data transactions mandated by HIPAA and identify the steps a provider will need to take as part of the ASC X12 005010 transition.

“HIMSS and our medical banking and financial systems community welcome the opportunity to work with the Accredited Standards Committee X12 to build awareness and better educate our diverse audiences, on the value of efficient data exchange in health care,” said John Casillas, HIMSS Senior Vice President, Business-Centered Systems. “With this MoU, our organizations can work together to build relationships and develop educational programming that improves the delivery of health care.”

About HIMSS
HIMSS is a cause-based, not-for-profit organization exclusively focused on providing global leadership for the optimal use of information technology (IT) and management systems for the betterment of healthcare. Founded 50 years ago, HIMSS and its related organizations have offices in Chicago, Washington, DC, Brussels, Singapore, Leipzig, and other locations across the United States. HIMSS represents more than 30,000 individual members, of which two thirds work in healthcare provider, governmental and not-for-profit organizations. HIMSS also includes over 470 corporate members and more than 85 not-for-profit organizations that share our mission of transforming healthcare through the effective use of information technology and management systems. HIMSS frames and leads healthcare practices and public policy through its content expertise, professional development, and research initiatives designed to promote information and management systems’ contributions to improving the quality, safety, access, and cost-effectiveness of patient care. To learn more about HIMSS and to find out how to join us and our members in advancing our cause, please visit our website at www.himss.org.

About X12
ASC X12, chartered by the American National Standards Institute more than 30 years ago, develops and maintains EDI and CICA standards along with XML schemas which drive business processes globally. The diverse membership of ASC X12 includes technologists and business process experts, encompassing health care, insurance, transportation, finance, government, supply chain and other industries. For more information, visit the ASC X12 website at www.x12.org

For HIMSS information contact:
Joyce Lofstrom
HIMSS
(312) 915-9237
Email Contact

For ASC X12 information contact:
ASC X12
(703) 970-4480
Email Contact

Filed Under: Facilities And Providers

CMU’s College of Medicine Teams Up With Saginaw Medical Providers

Posted on December 2, 2010 Written by Annalyn Frame

SOURCE: Central Michigan University

MOUNT PLEASANT, MI–(Marketwire – December 2, 2010) – Following more than two years of exploration, comprehensive study and due diligence, Central Michigan University will establish a relationship with Synergy Medical Education Alliance, Covenant Healthcare and St. Mary’s of Michigan in Saginaw, Mich., through its College of Medicine.

The CMU Board of Trustees, at its Dec. 2 meeting, voted unanimously to establish a new 501(c)(3) Michigan nonprofit corporation, Central Health Advancement Solutions, to serve as the University’s participant in clinical practice entities and medical education relationships.

The boards of St. Mary’s of Michigan and Synergy Medical Education Alliance must approve the agreement. It is anticipated that the required board approvals will be secured by mid-December. Covenant Healthcare’s board has already approved the agreement.

Under the terms of the agreement, if approved, CMU will join in the Synergy Medical Education Alliance partnership and the organization will be renamed CMU Medical Education Partners.

CMU has been engaged in the Saginaw community since the 1970s providing extended and distance learning programs and remains committed to enhancing its engagement through a facility in the Saginaw area to support medical education and clinical practice needs.

In other College of Medicine action, CMU trustees established a Doctor of Medicine degree. The four-year curriculum, with an emphasis on placing doctors in rural settings, will focus on evidence-based practice, patient-centered care, team-based learning and practice, and self-directed lifelong learning.

To view today’s PowerPoint presentation to the board visit http://www.cmich.edu/documents/college_of_medicine/collegeofmedicinepresentation_120210.pdf.

To learn more about CMU’s College of Medicine visit http://www.cmich.edu/med.

For additional news from Central Michigan University, visit the CMU Media Channel at http://www.cmich.edu/mediachannel.

Click here to see all recent news from this company

Filed Under: Facilities And Providers

University of Chicago Medical Center Runs Critical Patient Applications on Oracle’s Sun SPARC Enterprise Servers and Oracle Solaris

Posted on December 2, 2010 Written by Annalyn Frame

SOURCE: Oracle Corporation

Mission-Critical Servers Deliver Record-Breaking Performance and Scalability

REDWOOD SHORES, CA–(Marketwire – December 2, 2010) – Oracle (NASDAQ: ORCL)

News Facts

  • To provide the best patient care, the University of Chicago Medical Center is running its critical patient care applications on Oracle’s Sun SPARC Enterprise M-Series Servers with Oracle Solaris.
  • The University of Chicago Medical Center (UCMC) is an academic medical center comprised of numerous hospitals, including Bernard A. Mitchell Hospital, Comer Children’s Hospital, Chicago Lying-in Hospital, Duchossois Center for Advanced Medicine and the University of Chicago Pritzker School of Medicine, as well as physician offices in several Chicago locations.
  • UCMC chose Oracle’s Sun SPARC Enterprise M-Series servers running Oracle Solaris for their high level of performance, scalability and availability to run its mission-critical applications, including the Epic Electronic Medical Record (EMR) and Computerized Physician Order Entry (CPOE) systems.
  • More than 6,000 clinical staff rely on the Epic EMR system to deliver 24×7 secure access to all relevant information necessary to provide high-quality patient care, including lab results, orders, documentation on care plans, operating room management and scheduling, reporting and patient portals.
  • With Oracle’s Sun SPARC Enterprise M-Series servers running Oracle Solaris, UCMC has increased performance by 40 percent, decreased maintenance costs and reduced power and cooling by 63 percent in the datacenter.
  • With the new platform, nurses and physicians experience rapid response times, enabling them to provide patient care in a more timely and efficient manner, which is key in hospital and critical-care environments.
  • Part of UCMC’s strategic five-year plan, the SPARC servers provide the capacity to support new initiatives and continued growth, including the deployment of new EMR modules and technology to support a new hospital coming online in 2013.
  • UCMC invested in Oracle’s Sun SPARC Enterprise M-Series servers with Oracle Solaris in March 2010.

Supporting Quote

  • “Oracle’s Sun SPARC Enterprise servers provide us with a secure and reliable platform to run our mission-critical patient care applications and the ability to easily scale to accommodate future growth,” said Michael Sorensen, Executive Director and CTO, IT Services, the University of Chicago Medical Center. “The new platform has delivered dramatic results, including significantly faster response times, which is instrumental in our ability to provide patients with the best care.”

Supporting Resources

  • University of Chicago Medical Center
  • Oracle’s Sun SPARC Enterprise M-Series Servers
  • Oracle Solaris
  • Oracle in Healthcare
  • Follow Oracle Health Sciences on Twitter
  • Join the Oracle Health Sciences Community on Facebook

About Oracle
Oracle (NASDAQ: ORCL) is the world’s most complete, open and integrated business software and hardware systems company. For more information about Oracle, please visit http://www.oracle.com.

Trademarks
Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.

Contact Info

Nicole Maloney
Oracle
+1.650.506.0806
Email Contact

Susan Vander May
Blanc and Otus for Oracle
+1.415.341.3529
Email Contact

Filed Under: Facilities And Providers

UPDATE: Cardiothoracic Surgeons Group and The Toledo Hospital Recognized Among Nation’s Top Hospitals for Heart Surgery

Posted on December 2, 2010 Written by Annalyn Frame

SOURCE: ProMedica Health System

TOLEDO, OH–(Marketwire – December 2, 2010) – Cardiothoracic Surgeons for Northwest Ohio and The Toledo Hospital are now in the nation’s top 12% of hospitals for heart surgery. This is according to a three-star comprehensive rating system, developed by The Society of Thoracic Surgeons (STS), which compares the quality of heart surgery in hospitals across the country. A three-star rating is the highest designation that a hospital can attain for quality and clinical excellence. Cardiothoracic Surgeons for Northwest Ohio was compared to more than 1,000 surgical groups.

Hospitals are scored on performance in the following four categories — patient survival, absence of surgical complications, recommended medications, and optimal surgical technique. The ratings reflect results from isolated heart-bypass operations called coronary artery bypass grafting to newer versions, which include minimally invasive bypass and other complex cardiac procedures.

“I am grateful to my partners and colleagues at The Toledo Hospital who have worked diligently for years to reach this incredible milestone,” said Michael Moront, MD, senior partner, Cardiothoracic Surgeons for Northwest Ohio. “When patients enter our doors, they can feel confident that they will be receiving the very best care from one of the nation’s leading medical groups.”

Consumers can easily see how surgical groups compare with national benchmarks for survival, complications, and other measures by visiting www.consumerhealthreports.org.

About STS
The Society of Thoracic Surgeons is a not-for-profit organization representing more than 6,000 surgeons, researchers and allied health care professionals worldwide who are dedicated to ensuring the best possible outcomes for surgeries of the heart, lung, and esophagus as well as other surgical procedures within the chest. Founded in 1964, the mission of STS is to enhance the ability of cardiothoracic surgeons to provide the highest quality patient care through education, research, and advocacy. Its National Adult Cardiac Surgery Database includes more than 4 million surgical records and covers roughly 90% of the more than 1,000 surgical groups in the U.S. that perform cardiac surgery, making it the largest such registry in the world.

About Cardiothoracic Surgeons for Northwest Ohio
Cardiothoracic Surgeons for Northwest Ohio is a member of ProMedica Heart and Vascular Institutes, a collaboration of physicians, technology and specialty services. The group provides a comprehensive scope of leading edge patient care and state-of-the-art surgical procedures, including minimally invasive procedures, bloodless surgery, pediatric cardiac surgery, aortic valve repair and replacement and more. Its team of board-certified physicians, specialists and medical staff make up the largest cardiothoracic surgical program in northwest Ohio.

For more information about cardiac services at ProMedica Health System, visit www.promedica.org

Cardiothoracic Surgeons for Northwest Ohio and The Toledo Hospital are members of ProMedica Health System. ProMedica, a mission-based organization, was formed in 1986 and is a Toledo, Ohio-based, not-for-profit healthcare organization with more than 14,000 employees; 3,000 physicians and more than 306 facilities in Ohio and Michigan. ProMedica serves more than 2.73 million patients annually and includes 11 hospitals; ProMedica Continuum Services with senior, hospice, rehabilitation, and integrative services; ProMedica Physician Group, a network of more than 315 primary care and specialty physicians; and Paramount Health Care, the largest HMO in northwest Ohio. For more information, please visit www.promedica.org.

Contact:
Tedra White
Office: 419-469-3716
Cell: 419-262-0371

Filed Under: Facilities And Providers

SRSsoft to Attain Government Certification for EMR Delivering Productivity-Focused Meaningful Use

Posted on December 2, 2010 Written by Annalyn Frame

SOURCE: SRSsoft

MONTVALE, NJ–(Marketwire – December 2, 2010) – SRS, the leader in productivity-enhancing EMR technology and services for high-performance specialty practices, today announced that it will seek certification of its EMR by the Office of the National Coordinator for Health Information Technology (ONC) under the American Recovery and Reinvestment Act (ARRA). Physicians will be able to use the EMR to successfully demonstrate meaningful use and qualify for the government’s incentives. SRS is unique among EMRs in its approach to meaningful use — combining the government’s requirements and desire for data with the acknowledged productivity and efficiency benefits that over 5,000 providers are already experiencing, and for which SRS is valued.

“SRS is unwavering in its adherence to a set of principles that are physician-based and productivity-driven,” says Evan Steele, CEO of SRSsoft. “Our product-development resources are consistently focused on providing physicians with tools that enable them to deliver the highest quality patient care in the most efficient manner. We listen to our customers, and we represent ‘the voice of the physicians,’ which includes advocating for their interests in Washington.

“We have been analyzing the legislation since its passage in February 2009 and continue to evaluate the impact that meeting meaningful use measures will have on physician productivity. In addition, we have challenged the program’s relevance for specialists. Since the release of the Final Rule on meaningful use a few months ago, the landscape has shifted, and several factors have influenced our decision to move forward with certification. Most recently, David Blumenthal’s clarification of the exclusions that can be claimed by many specialists has made participation more inviting. Our clients — primary care and specialists — who are interested in pursuing meaningful use want to have the assurance that the capability will be available to them.”

According to Steele, “The development team at SRS has been working diligently to incorporate the government’s data and communication requirements into our workflow-driven EMR. The uniqueness of the SRS approach to electronic medical records software — Unified Desktop™, open architecture, and browser-based platform — is the key to our ability to deliver productivity-focused meaningful use.”

About SRS
SRS is the leading provider of productivity-enhancing EMR technology and services for high-performance specialty practices — with a successful adoption rate unparalleled in the industry. Offered via the Unified Desktop™, its robust EMR, SRS CareTracker PM, and SRS PACS increase speed and efficiency, free physicians’ time, boost revenue, slash overhead, and enhance patient care and satisfaction. For more information on SRS, visit www.srssoft.com, e-mail [email protected], fax 201.802.1301, or call 800.288.8369.

Media Contact
Jeremy Duca
SRSsoft
800.288.8369
Email Contact

Filed Under: Facilities And Providers

Proteonomix, Inc. (PROT) Announces Investor Update and New Company Website

Posted on December 2, 2010 Written by Annalyn Frame

SOURCE: Proteonomix

MOUNTAINSIDE, NJ–(Marketwire – December 2, 2010) – Proteonomix, Inc. (OTCBB: PROT) (“Proteonomix” or the “Company”) announced today that it has updated its corporate website (http://www.proteonomix.com/) to reflect the dynamic growth and investment opportunity that exists today.

Michael Cohen, CEO stated: “The mission of Proteonomix, Inc. is to achieve a leadership position in life enhancing regenerative stem cell therapies, services, and products through a combination of first to market technologies and innovative clinical trial strategies. Stem cell treatment provides much promise for the treatment of diseases previously regarded as incurable. Through years of research and development, Proteonomix has developed breakthroughs in stem cell therapies for disease and injury, identification biomarkers and reproductive cell/tissue laboratory services.”

“Proteonomix is now actively negotiating strategic partnerships and opportunities for its breakthrough products and technology. We are currently in negotiations to joint venture our patents and intellectual properties with various entities and will be updating the investment community as these milestones are completed,” concluded Mr. Cohen.

About Proteonomix, Inc.
Proteonomix is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteoderm, Inc. is a wholly owned subsidiary of Proteonomix that has recently opened its retail web site, Proteoderm.com, and begun accepting pre-orders for its anti-aging line of skin care products. StromaCel, Inc.’s goal is the development of therapeutic modalities for the treatment of Cardiovascular Disease (CVD). StromaCel, Inc. is pursuing the licensing of other technologies for therapeutic use. National Stem Cell, Inc. is Proteonomix’s operating subsidiary. The Sperm Bank of New York, Inc. is a fully operational tissue bank. Proteonomix Regenerative Translational Medicine Institute, Inc. (“PRTMI”) intends to focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine. Proteonomix intends to create and dedicate a subsidiary to each of its technologies. Please also visit http://www.proteonomix.com/, http://www.proteoderm.com/, http://www.otcqb.com/ and http://www.sec.gov/.

Forward-looking statements: Certain statements contained herein are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). Proteonomix, Inc. cautions that statements made in this press release constitute forward-looking statements and makes no guarantee of future performance. Actual results or developments may differ materially from projections. More specifically, the investment may never occur negating the agreement, product performance and/or side effects may necessitate termination of the joint venture, the implementation of the agreement may not succeed and inadequate or no business may develop causing the failure of the joint venture and there are inherent risks in foreign operations, particularly those in the Mideast. Forward-looking statements are based on estimates and opinions of management at the time statements are made.

Contact:
Public Relations:
Constellation Asset Management, LLC
415-524-8500

Click here to see all recent news from this company

Filed Under: Facilities And Providers

CRC Health Group, New Life Lodge Drug and Alcohol Addiction Treatment Center Expand Services With Multi-Facility Acquisition

Posted on December 2, 2010 Written by Annalyn Frame

SOURCE: CRC Health Group

Additional Five Facilities to Provide Outpatient and In-Home Treatment Services, Options for the One Hundred Thousand-Plus TN Residents Who Need but Do Not Currently Receive Addiction Treatment

BURNS, TN–(Marketwire – December 2, 2010) – New Life Lodge drug and alcohol addiction treatment center, in conjunction with parent company CRC Health Group, the nation’s largest provider of behavioral health and addiction treatment services, today announced the completion of the multi-facility acquisition of Recovery Living Services (RLS) in Tennessee. 

“We are pleased to acquire RLS, which has been providing high quality addiction treatment services for over five years, and to expand the outreach and breadth of services of New Life Lodge,” said Jerry Rhodes, President of the Recovery Division of CRC Health Group. “There are a number of Tennesseans who are dependent on drugs or alcohol and are in desperate need of quality recovery services. We want to help these individuals in their pursuit to reclaim their lives.”

According to the Substance Abuse and Mental Health Services Administration’s (SAMHSA) most recent National Survey on Drug Use and Health, approximately 444,000 (9%) of Tennessee citizens ages 12 or older reported past month use of an illicit drug, with 151,000 citizens reporting dependence or abuse of an illicit drug within the past year. Yet in 2008 (most recent year of data), there were only 9,806 admissions to drug/alcohol treatment centers in Tennessee. Approximately 129,000 Tennessee citizens reported needing but not receiving treatment for illicit drug use.

RLS provides substance abuse treatment for adults and adolescents as well as in-home behavioral health counseling services for at-risk youth. The acquired facilities — located in Downtown Knoxville, West Knoxville, Cookeville, Jamestown and Jacksboro — will continue to provide intensive outpatient program (IOP) services, outpatient opiate (Suboxone-based) detoxification services, and intensive in-home services. In addition, plans are underway to open two additional facilities in Chattanooga and Memphis.

Rebecca Gaskin, LCSW, CAC, MSW, MBA and current Executive Director of New Life Lodge, will oversee the additional facilities. Current CEO of Recovery Living Services, George Massengill, will stay on with CRC Health Group.

“I am very excited to have Recovery Living Services join the New Life Lodge family to serve persons struggling with substance abuse disorders throughout the state of Tennessee,” said Gaskin. “New Life Lodge is committed to providing high quality, effective treatment and RLS has demonstrated the same commitment in outpatient treatment settings throughout the eastern Tennessee area. This partnership will allow New Life Lodge to offer a seamless array of treatment opportunities for individuals to optimize their residential treatment experience and support them as they integrate back into their home environments.”

Gaskin added, “We hope to make our services widely available to those struggling with addiction by expanding our outpatient facilities across the state.”

New Life Lodge has been providing rehabilitation and treatment services for adults and adolescents struggling with alcohol and drug dependency for over 25 years. The treatment center acknowledges that addiction affects the entire family and therefore embraces the family as well as the individual to provide personalized treatment services. Under the supervision of licensed professionals, New Life Lodge has built a nationally recognized reputation and established long-standing relationships within the medical and mental health communities. The program is licensed by the Tennessee Department of Health and the Tennessee Department of Healthcare Facilities, and is CARF-accredited. For more information, visit www.newlifelodge.com.

New Life Lodge is a member of CRC Health Group, the most comprehensive network of specialized behavioral care services in the nation. CRC offers the largest array of personalized treatment options, allowing individuals, families and professionals to choose the most appropriate treatment setting for their behavioral, addiction, weight management and therapeutic education needs. CRC is committed to making its services widely and easily available, while maintaining a passion for delivering advanced treatment. Since 1995, CRC has been helping individuals and families reclaim and enrich their lives.
For more information, visit www.crchealth.com or call (877) 637-6237.

CONTACT:
Kristen Hayes, Communications Director
CRC Health Group
Email Contact
(949) 589-1765

Filed Under: Facilities And Providers

  • 1
  • 2
  • 3
  • …
  • 16
  • Next Page »

Search Our Site

Categories

  • AARP
  • AI
  • Blue Cross Blue Shield
  • Canadian Health Care System
  • CIGNA HealthCare
  • COVID-19
  • Facilities And Providers
  • FDA
  • Health Clinics
  • Healthcare Companies
  • Healthcare Plan News
  • Humana
  • MedBasics
  • Medical And Healthcare
  • Medical Malpractice
  • Medicare
  • Senior News
  • The SCOOTER Store

Pages

  • 1199 National Benefit Fund
  • A Little about Drug Preparation and Formulation Development
  • About Us
  • Achieve Your Weight Goals with Advanced Thermogenic with NMN
  • Affordable Health Insurance
  • Anavar: A Deep Dive into Athletic Benefits, Potential Side Effects, and Weight Loss Applications
    • Anavar Cycle: Benefits, Dosages, and Side Effects
      • Anavar Cycle: Benefits, Dosages, and Side Effects
    • Deca Durabolin vs Anavar: Comparing Performance Enhancers
  • B12 Elite Elixir: Vitalizing Your Health and Energy Levels
  • Benefits of Hiring a Senior Caregiving Service
  • Catastrophic Health Insurance
  • Cheap Health Insurance
  • Cheap Health Insurance Plans
  • Child Health Insurance Plans
  • Choosing a Health Insurance Plan
  • Christian Health Insurance
  • Dental Assistants and Their Future
  • Disclaimer
  • Dr. Howard Bellin: Questions about Rhinoplasty
  • Elite Health Online Dual Stack approach: Unlock your weight loss potential
  • Elite Thermogenic Formula: A Game-Changer in Weight Management and Metabolic Health
  • Finding the Right Dentist
  • Get Your Winks in Blink
  • Harnessing the Power of HGH for Vitality and Youthfulness
  • Health Insurance
  • Health Insurance Plans For Family
  • Health Sharing Plans
  • Healthcare and Hospitals: Disinfection is Key
  • High Deductible Health Plans
  • Home Care Employment in Arizona
  • Hormone Replacement Therapy
    • Harmonizing Body and Spirit: Navigating through Hormone Replacement Therapy
    • Hormone Replacement Therapy (HRT) – A Double-Edged Sword
    • Hormone Replacement Therapy (HRT): A Guide to Rebalancing Hormones
    • Hormone Replacement Therapy (HRT): Balancing the Benefits, Side Effects, and Menopausal Relief
    • Hormone Replacement Therapy: Benefits & Considerations
  • Hot ROCS: The Ultimate Solution for Enhanced Energy and Metabolism
  • How A Medical Weight Loss Plan Can Help You Get The Figure You Want
  • How Ketamine Therapy Helps Fight Depression
  • How Orthotic Insoles Improve Your Health
  • Individual Health Insurance Plans
  • John Kim Austin
  • Ketamine Uses and Benefits
  • List of Health Insurance Companies
  • Low Income Health Insurance
  • Medical Device CROs: The Role in Research and Development
  • Medical Malpractice
  • Medical Research Consultants
  • Menopause and HRT
  • Mounjaro (Tirzepatide): A Breakthrough in Diabetes and Obesity Management
  • Nicotinamide Adenine Dinucleotide – Unleashing Vital Molecule Power for Optimal health
    • Unlocking the Power of NMN in Our Advanced Thermogenic and NMN Formula
  • Oxytocin Benefits
    • Oxytocin: The Love Hormone Decoded
    • Oxytocin: The Love Hormone’s Role in Bonding and Beyond
  • Oxytocin Benefits and Hormone Therapy
  • Peptides: The Future of Health and Wellness
    • Semax Peptide – A Glimpse into Nootropic Advancements
  • Personal Lubricants for Women – Liven Up Your Life!
  • Phentermine: Benefits, Usage, and Potential Side Effects
  • Privacy Policy
  • Private Health Insurance Plans
  • Rapamycin, the anti-aging marvel and its multidimensional health benefits
    • Rapamycin: The Anti-Aging Wonder Drug
  • Rhesus Negative
  • Self Employed Health Insurance
  • Semaglutide: A Safe and Effective Alternative to Surgical Weight Loss
    • Semaglutide and its Weight Loss Benefits
    • Semaglutide: A Revolutionary Treatment Explored
    • Semaglutide: Bridging Diabetes Treatment and Weight Loss While Managing Side Effects
    • Semaglutide: Revolutionizing Weight Loss and Diabetes Management
    • Semaglutide: Transforming Weight Management and Glycemic Control
  • Short Term Health Insurance Plans
  • Student Health Insurance Plans
  • Temporary Health Insurance
  • Terms of Use
  • Testosterone Replacement Therapy Insights
    • Exploring the HCG Diet: Unveiling a Unique Pathway Towards Weight Management
    • Testosterone for Females: Balancing Health & Wellness
      • Testosterone for Females: Exploration of Hormonal Balance and Health
    • Testosterone Replacement Therapy (TRT): A Comprehensive Guide
    • Unlocking the Pivotal Role of Testosterone in Holistic Wellbeing
  • Testosterone Therapy: Weighing the Benefits, Risks, and Identifying Symptoms
    • The Vital Role of Testosterone in Health & Well-being
  • The Basic Building Blocks For a Sustained, Healthy Diet
  • The Importance of Clinical Study Software
  • The Marvels and Misgivings of Rapamycin: A Glimpse into Anti-aging and Longevity Benefits
  • The Use of Post Cycle Therapy Supplements
  • Timeless Beauty Med Spa: Elevating Skincare in Dallas, Texas
    • Achieve Your Body Goals with Emsculpt Neo: Now Available at Timeless Beauty Med Spa in Dallas, Texas
    • The Ultimate Guide to Facials: A Path to Radiant Skin
  • Travel Health Insurance
  • Ultimate Guide for Anavar Cycles
  • Understanding Metformin: Benefits and Insights
    • Metformin: A Pillar of Hope in Weight Loss Journeys
    • Metformin: The Multifaceted Medication for Modern Health Challenges
  • Understanding Nandrolone: Benefits and Uses
    • Demystifying Nandrolone: Uses, Potential Benefits, and Considerations
    • Nandrolone for Joint Pain: Efficacy, Benefits, and Considerations
    • Nandrolone: From Muscle Building to Therapeutic Uses and Side Effects
  • Unleash your Potential with Nandrolone & Deca Durabolin
  • Unleashing Glutathione’s Power: The Key to Anti-Aging and Health
  • Unlocking Testosterone’s Power: A Comprehensive Guide to Better Health
  • Winstrol – Beyond the World of Bodybuilding
    • Unlocking the Potential of Winstrol: Dosage, Benefits, and Risks

Entity Map

Disclaimer

All content on Health Plan News and information provided on this website is for informational purposes only and is not intended as a substitute for advice from your physician or other healthcare professional. You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. Always consult with a healthcare professional before starting any diet, exercise, or supplementation program, before taking any medication, or if you have or suspect you might have a health problem.

Copyright © 2026 - Privacy Policy - Terms of Use - Disclaimer